

<html
  xmlns:o="urn:schemas-microsoft-com:office:office"
  xmlns:x="urn:schemas-microsoft-com:office:excel"
  xmlns="http://www.w3.org/TR/REC-html40">

<head>
<title>Grant Fact Sheet Search | Brownfields | US EPA</title>
</head>
<body>


  <h1>IRIS Chemical Search</h1>

  

<table class="searchResults-table" id="searchMain" summary="This table contains the results of your chemical search. The columns change depending upon the filters selected to give you more relevant information.">
<thead>
  <tr>
	
    <th scope="col">Chemical Name</th>
	
    <th scope="col">CASRN</th>
	
    <th scope="col">Exposure Route</th>
	
    <th scope="col">Assessment Type</th>
	
    <th scope="col">Critical Effect or Tumor Type</th>
	
    <th scope="col">WOE Characterization</th>
	
    <th scope="col">Toxicity Value Type</th>
	
    <th scope="col">Toxicity Value</th>
	
  </tr>
</thead>
<tbody>
  
  <tr>
	
		<td>
			<a id='Acenaphthene_1' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=442'>Acenaphthene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000083329'>83-32-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acephate_2' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=354'>Acephate</a> 
		</td>
	
		<td>
			<span id='sortby_000000030560191'>30560-19-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Inhibition of brain ChE 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acetaldehyde_3' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=290'>Acetaldehyde</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075070'>75-07-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Nasal squamous cell carcinoma or adenocarcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.2x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acetaldehyde_4' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=290'>Acetaldehyde</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075070'>75-07-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degeneration of olfactory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acetochlor_5' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=521'>Acetochlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000034256821'>34256-82-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Salivation, increased ALT and ornithine carbamyl transferase; significant increases in triglyceride and decreased blood glucose levels; histopathological changes in kidneys and testes of males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acetone_6' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=128'>Acetone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067641'>67-64-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nephropathy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acetonitrile_7' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=205'>Acetonitrile</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075058'>75-05-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mortality 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acetophenone_8' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=321'>Acetophenone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098862'>98-86-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			General Toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acifluorfen,_sodium_9' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=192'>Acifluorfen, sodium</a> 
		</td>
	
		<td>
			<span id='sortby_000000062476599'>62476-59-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mortality and kidney lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrolein_10' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=364'>Acrolein</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107028'>107-02-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nasal lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-5</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrolein_11' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=364'>Acrolein</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107028'>107-02-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased survival 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylamide_12' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=286'>Acrylamide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079061'>79-06-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degenerative nerve changes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylamide_13' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=286'>Acrylamide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079061'>79-06-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degenerative nerve changes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylamide_14' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=286'>Acrylamide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079061'>79-06-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			thyroid tumors and tunica vaginalis mesotheliomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylamide_15' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=286'>Acrylamide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079061'>79-06-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			thyroid tumors and tunica vaginalis mesotheliomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylic_acid_16' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=2'>Acrylic acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079107'>79-10-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degeneration of the nasal olfactory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylic_acid_17' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=2'>Acrylic acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079107'>79-10-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced pup weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylonitrile_18' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=206'>Acrylonitrile</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107131'>107-13-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Respiratory cancer 
		</td>
	
		<td>
			B1 (Probable human carcinogen - based on limited evidence of carcinogenicity in humans) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6.8x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylonitrile_19' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=206'>Acrylonitrile</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107131'>107-13-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Brain and spinal cord astrocytomas, Zymbal gland carcinomas and stomach papillomas/ carcinomas 
		</td>
	
		<td>
			B1 (Probable human carcinogen - based on limited evidence of carcinogenicity in humans) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5.4x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Acrylonitrile_20' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=206'>Acrylonitrile</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107131'>107-13-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degeneration and inflammation of nasal respiratory epithelium; hyperplasia of mucous secreting cells 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Alachlor_21' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=129'>Alachlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000015972608'>15972-60-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hemosiderosis, hemolytic anemia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Alar_22' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=287'>Alar</a> 
		</td>
	
		<td>
			<span id='sortby_000000001596845'>1596-84-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aldicarb_23' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=3'>Aldicarb</a> 
		</td>
	
		<td>
			<span id='sortby_000000000116063'>116-06-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Sweating as clinical sign of AChe inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aldicarb_sulfone_24' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=312'>Aldicarb sulfone</a> 
		</td>
	
		<td>
			<span id='sortby_000000001646884'>1646-88-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Brain ChE inhibition in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aldrin_25' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=130'>Aldrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000309002'>309-00-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aldrin_26' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=130'>Aldrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000309002'>309-00-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.7x10<sup>1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aldrin_27' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=130'>Aldrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000309002'>309-00-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.9x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ally_28' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=288'>Ally</a> 
		</td>
	
		<td>
			<span id='sortby_000000074223646'>74223-64-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Allyl_alcohol_29' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=4'>Allyl alcohol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107186'>107-18-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Impaired renal function and increased liver and kidney weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Allyl_chloride_30' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=387'>Allyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107051'>107-05-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Functional and histological peripheral neurotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aluminum_phosphide_31' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=5'>Aluminum phosphide</a> 
		</td>
	
		<td>
			<span id='sortby_000000020859738'>20859-73-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Body weight and clinical parameters 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Amdro_32' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=207'>Amdro</a> 
		</td>
	
		<td>
			<span id='sortby_000000067485294'>67485-29-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased organ weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ametryn_33' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=208'>Ametryn</a> 
		</td>
	
		<td>
			<span id='sortby_000000000834128'>834-12-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Amitraz_34' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=334'>Amitraz</a> 
		</td>
	
		<td>
			<span id='sortby_000000033089611'>33089-61-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased mean blood sugar concentration; slight hypothermia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ammonia_35' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=422'>Ammonia</a> 
		</td>
	
		<td>
			<span id='sortby_000000007664417'>7664-41-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased lung function and respiratory symptoms 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ammonium_sulfamate_36' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=7'>Ammonium sulfamate</a> 
		</td>
	
		<td>
			<span id='sortby_000000007773060'>7773-06-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decrease in body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aniline_37' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=350'>Aniline</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062533'>62-53-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Spleen, combined fibrosarcoma, stromal sarcoma, capsular sarcoma and hemangiosarcoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5.7x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aniline_38' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=350'>Aniline</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062533'>62-53-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Methemoglobin increase, spleen toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Anthracene_39' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=434'>Anthracene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000120127'>120-12-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No observed effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Antimony_40' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=6'>Antimony</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440360'>7440-36-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Longevity, blood glucose, and cholesterol 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Antimony_trioxide_41' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=676'>Antimony trioxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000001309644'>1309-64-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Pulmonary toxicity, chronic interstitial inflammation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Apollo_42' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=8'>Apollo</a> 
		</td>
	
		<td>
			<span id='sortby_000000074115245'>74115-24-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver effects; organ weight changes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aramite_43' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=473'>Aramite</a> 
		</td>
	
		<td>
			<span id='sortby_000000000140578'>140-57-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Neoplastic liver nodules and carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.5x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aramite_44' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=473'>Aramite</a> 
		</td>
	
		<td>
			<span id='sortby_000000000140578'>140-57-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Neoplastic liver nodules and carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			7.1x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aroclor_1016_45' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=462'>Aroclor 1016</a> 
		</td>
	
		<td>
			<span id='sortby_000000012674112'>12674-11-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced birth weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Aroclor_1254_46' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=389'>Aroclor 1254</a> 
		</td>
	
		<td>
			<span id='sortby_000000011097691'>11097-69-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Ocular exudate, inflamed and prominent Meibomian glands, distorted growth of finger and toe nails; decreased antibody (IgG and IgM) response to sheep erythrocytes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Arsenic,_Inorganic_47' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=278'>Arsenic, Inorganic</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440382'>7440-38-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung cancer 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.3x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Arsenic,_Inorganic_48' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=278'>Arsenic, Inorganic</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440382'>7440-38-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Skin cancer 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.5  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Arsenic,_Inorganic_49' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=278'>Arsenic, Inorganic</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440382'>7440-38-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hyperpigmentation, keratosis and possible vascular complications 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Arsine_50' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=672'>Arsine</a> 
		</td>
	
		<td>
			<span id='sortby_000000007784421'>7784-42-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased hemolysis, abnormal RBC morphology, and increased spleen weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>-5</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Asbestos_51' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=371'>Asbestos</a> 
		</td>
	
		<td>
			<span id='sortby_000000001332214'>1332-21-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung cancer and mesothelioma 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.3x10<sup>-1</sup>  per f/mL </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Assure_52' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=335'>Assure</a> 
		</td>
	
		<td>
			<span id='sortby_000000076578148'>76578-14-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver cell enlargement 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Asulam_53' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=284'>Asulam</a> 
		</td>
	
		<td>
			<span id='sortby_000000003337711'>3337-71-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Lower ovarian weight, lower liver/body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Atrazine_54' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=209'>Atrazine</a> 
		</td>
	
		<td>
			<span id='sortby_000000001912249'>1912-24-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Avermectin_B1_55' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=381'>Avermectin B1</a> 
		</td>
	
		<td>
			<span id='sortby_000000065195553'>65195-55-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased retinal folds in weanlings, decreased viability and lactation indices, decreased pup body weight, increase of dead pups at birth 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Azobenzene_56' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=351'>Azobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000103333'>103-33-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Abdominal cavity sarcomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3.1x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Azobenzene_57' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=351'>Azobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000103333'>103-33-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Abdominal cavity sarcomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.1x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Barium_and_Compounds_58' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=10'>Barium and Compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440393'>7440-39-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nephropathy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Baygon_59' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=210'>Baygon</a> 
		</td>
	
		<td>
			<span id='sortby_000000000114261'>114-26-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mild cholinergic symptoms and RBD ChE inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bayleton_60' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=131'>Bayleton</a> 
		</td>
	
		<td>
			<span id='sortby_000000043121433'>43121-43-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain, erythrocyte count and hemoglobin level 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Baythroid_61' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=132'>Baythroid</a> 
		</td>
	
		<td>
			<span id='sortby_000000068359375'>68359-37-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weights in males, inflammatory foci in kidneys of females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benefin_62' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=133'>Benefin</a> 
		</td>
	
		<td>
			<span id='sortby_000000001861401'>1861-40-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Depressed erythrocyte counts 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benomyl_63' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=11'>Benomyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000017804352'>17804-35-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pup weanling weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bentazon_(Basagran)_64' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=134'>Bentazon (Basagran)</a> 
		</td>
	
		<td>
			<span id='sortby_000000025057890'>25057-89-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Blood loss into the gastrointestinal tract; coagulation defect in male and female dogs 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3.0x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzaldehyde_65' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=332'>Benzaldehyde</a> 
		</td>
	
		<td>
			<span id='sortby_000000000100527'>100-52-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Forestomach lesions, kidney toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzene_66' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=276'>Benzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071432'>71-43-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Leukemia 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.2x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzene_67' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=276'>Benzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071432'>71-43-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Leukemia 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5.5x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzene_68' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=276'>Benzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071432'>71-43-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased lymphocyte count 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzene_69' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=276'>Benzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071432'>71-43-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased lymphocyte count 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4.0x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzene_70' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=276'>Benzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071432'>71-43-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Leukemia 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.5x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzene_71' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=276'>Benzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071432'>71-43-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Leukemia 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			7.8x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzidine_72' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=135'>Benzidine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000092875'>92-87-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Bladder tumors 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6.7x10<sup>-2</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzidine_73' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=135'>Benzidine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000092875'>92-87-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Brain cell vacuolization; liver cell alterations in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzidine_74' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=135'>Benzidine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000092875'>92-87-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Bladder tumors 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.3x10<sup>2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzo[a]pyrene_(BaP)_75' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=136'>Benzo[a]pyrene (BaP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050328'>50-32-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased thymus weight and serum IgM 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzo[a]pyrene_(BaP)_76' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=136'>Benzo[a]pyrene (BaP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050328'>50-32-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased embryo/fetal survival 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-6</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzo[a]pyrene_(BaP)_77' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=136'>Benzo[a]pyrene (BaP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050328'>50-32-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			forestomach, esophagus, tongue, and larynx tumors 
		</td>
	
		<td>
			Carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzo[a]pyrene_(BaP)_78' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=136'>Benzo[a]pyrene (BaP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050328'>50-32-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced ovulation rate and ovary weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-6</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzo[a]pyrene_(BaP)_79' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=136'>Benzo[a]pyrene (BaP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050328'>50-32-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurobehavioral changes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzo[a]pyrene_(BaP)_80' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=136'>Benzo[a]pyrene (BaP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050328'>50-32-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased ovarian follicles and ovary weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzo[a]pyrene_(BaP)_81' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=136'>Benzo[a]pyrene (BaP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050328'>50-32-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Squamous cell neoplasia in the larynx, pharynx, trachea, nasal cavity, esophagus, and forestomach. 
		</td>
	
		<td>
			Carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzoic_acid_82' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=355'>Benzoic acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000065850'>65-85-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects observed 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzotrichloride_83' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=388'>Benzotrichloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098077'>98-07-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung, adenocarcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.3x10<sup>1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Benzyl_chloride_84' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=393'>Benzyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000100447'>100-44-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Thyroid, C-cell adenoma/ carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.7x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Beryllium_and_compounds_85' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=12'>Beryllium and compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440417'>7440-41-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Small intestinal lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Beryllium_and_compounds_86' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=12'>Beryllium and compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440417'>7440-41-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Beryllium sensitization and progression to CBD 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-5</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Beryllium_and_compounds_87' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=12'>Beryllium and compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440417'>7440-41-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung cancer 
		</td>
	
		<td>
			B1 (Probable human carcinogen - based on limited evidence of carcinogenicity in humans) (1986 guidelines)  Carcinogenic potential cannot be determined (1996 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.4x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bidrin_88' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=211'>Bidrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000141662'>141-66-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pup survival 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Biphenthrin_89' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=333'>Biphenthrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000082657043'>82657-04-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Tremors 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Biphenyl_90' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=13'>Biphenyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000000092524'>92-52-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver adenomas or carcinomas 
		</td>
	
		<td>
			Suggestive evidence of carcinogenic potential (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			8x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Biphenyl_91' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=13'>Biphenyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000000092524'>92-52-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal papillary mineralization in male F344 rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bis(2-chloro-1-methylethyl)_ether_92' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=407'>Bis(2-chloro-1-methylethyl) ether</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108601'>108-60-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decrease in hemoglobin and possible erythrocyte destruction 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bis(chloroethyl)ether_(BCEE)_93' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=137'>Bis(chloroethyl)ether (BCEE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000111444'>111-44-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3.3x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bis(chloroethyl)ether_(BCEE)_94' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=137'>Bis(chloroethyl)ether (BCEE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000111444'>111-44-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.1  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bis(chloromethyl)ether_(BCME)_95' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=375'>Bis(chloromethyl)ether (BCME)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542881'>542-88-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Respiratory tract tumors 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.2x10<sup>2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bis(chloromethyl)ether_(BCME)_96' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=375'>Bis(chloromethyl)ether (BCME)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542881'>542-88-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Respiratory tract tumors 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6.2x10<sup>-2</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bisphenol_A_97' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=356'>Bisphenol A</a> 
		</td>
	
		<td>
			<span id='sortby_000000000080057'>80-05-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced mean body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Boron_and_Compounds_98' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=410'>Boron and Compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440428'>7440-42-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased fetal weight 
(developmental) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromate_99' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1002'>Bromate</a> 
		</td>
	
		<td>
			<span id='sortby_000000015541454'>15541-45-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Testicular mesothelioma, renal tubular adenoma and carcinoma, and thyroid follicular cell adenoma and carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Carcinogenic potential cannot be determined (1996 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromate_100' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1002'>Bromate</a> 
		</td>
	
		<td>
			<span id='sortby_000000015541454'>15541-45-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal effects: urothelial hyperplasia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromobenzene_101' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1020'>Bromobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108861'>108-86-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatocellular cytomegaly in female B6C3F1 mice 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromobenzene_102' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1020'>Bromobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108861'>108-86-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatocellular cytomegaly in male B6C3F1 mice 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-3</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromobenzene_103' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1020'>Bromobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108861'>108-86-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatocellular cytomegaly in female B6C3F1 mice 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/m<sup>3</sup> (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromobenzene_104' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1020'>Bromobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108861'>108-86-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatocellular cytomegaly in male B6C3F1 mice 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromodichloromethane_105' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=213'>Bromodichloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075274'>75-27-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal cytomegaly 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromodichloromethane_106' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=213'>Bromodichloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075274'>75-27-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Kidney (tubular cell adenoma and tubular cell adenocarcinoma) 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			6.2x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromoform_107' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=214'>Bromoform</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075252'>75-25-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Neoplastic lesions in the large intestine 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7.9x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromoform_108' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=214'>Bromoform</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075252'>75-25-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromoform_109' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=214'>Bromoform</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075252'>75-25-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Neoplastic lesions in the large intestine 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.1x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromomethane_110' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=15'>Bromomethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000074839'>74-83-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degenerative and proliferative lesions of the olfactory epithelium of the nasal cavity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromomethane_111' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=15'>Bromomethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000074839'>74-83-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Epithelial hyperplasia of the forestomach 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromoxynil_112' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=289'>Bromoxynil</a> 
		</td>
	
		<td>
			<span id='sortby_000000001689845'>1689-84-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Bromoxynil_octanoate_113' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=138'>Bromoxynil octanoate</a> 
		</td>
	
		<td>
			<span id='sortby_000000001689992'>1689-99-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Butadiene_114' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=139'>1,3-Butadiene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106990'>106-99-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Leukemia 
		</td>
	
		<td>
			Carcinogenic to humans (1999 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Butadiene_115' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=139'>1,3-Butadiene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106990'>106-99-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Ovarian atrophy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Butyl_benzyl_phthalate_(BBP)_116' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=293'>Butyl benzyl phthalate (BBP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000085687'>85-68-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Significantly increased liver-to-body weight and liver-to-brain weight ratios 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Butylate_117' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=215'>Butylate</a> 
		</td>
	
		<td>
			<span id='sortby_000000002008415'>2008-41-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased relative liver weight in male dogs 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Butylphthalyl_butylglycolate_(BPBG)_118' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=16'>Butylphthalyl butylglycolate (BPBG)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000085701'>85-70-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effect 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cadmium_119' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=141'>Cadmium</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440439'>7440-43-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Significant proteinuria 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day (water) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cadmium_120' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=141'>Cadmium</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440439'>7440-43-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Significant proteinuria 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day (food) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cadmium_121' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=141'>Cadmium</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440439'>7440-43-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung, trachea, bronchus cancer deaths 
		</td>
	
		<td>
			B1 (Probable human carcinogen - based on limited evidence of carcinogenicity in humans) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.8x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Calcium_cyanide_122' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=17'>Calcium cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000592018'>592-01-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased cauda epididymis weight in male F344/N rats. The RfD for cyanide, free is presented in section I.A.3 of the hydrogen cyanide and cyanide salts IRIS Summary. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Caprolactam_123' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=357'>Caprolactam</a> 
		</td>
	
		<td>
			<span id='sortby_000000000105602'>105-60-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced offspring body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Captafol_124' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=216'>Captafol</a> 
		</td>
	
		<td>
			<span id='sortby_000000002425061'>2425-06-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney and bladder toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Captan_125' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=18'>Captan</a> 
		</td>
	
		<td>
			<span id='sortby_000000000133062'>133-06-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased mean body weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbaryl_126' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=19'>Carbaryl</a> 
		</td>
	
		<td>
			<span id='sortby_000000000063252'>63-25-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney and liver toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbofuran_127' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=218'>Carbofuran</a> 
		</td>
	
		<td>
			<span id='sortby_000000001563662'>1563-66-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			RBC and plasma cholinesterase inhibition, and testicular and uterine effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbon_disulfide_128' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=217'>Carbon disulfide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075150'>75-15-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Peripheral nervous system dysfunction 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbon_disulfide_129' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=217'>Carbon disulfide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075150'>75-15-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Fetal toxicity/ malformations 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbon_tetrachloride_130' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=20'>Carbon tetrachloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000056235'>56-23-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Elevated serum SDH activity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbon_tetrachloride_131' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=20'>Carbon tetrachloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000056235'>56-23-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Fatty changes in the liver 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbon_tetrachloride_132' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=20'>Carbon tetrachloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000056235'>56-23-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenoma or carcinoma 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbon_tetrachloride_133' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=20'>Carbon tetrachloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000056235'>56-23-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Pheochromocytoma 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carbosulfan_134' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=21'>Carbosulfan</a> 
		</td>
	
		<td>
			<span id='sortby_000000055285148'>55285-14-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Carboxin_135' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=22'>Carboxin</a> 
		</td>
	
		<td>
			<span id='sortby_000000005234684'>5234-68-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced weight gain, organ weight changes, increased mortality 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cerium_Oxide_and_Cerium_Compounds_136' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1018'>Cerium Oxide and Cerium Compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000001306383'>1306-38-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased incidence of alveolar epithelial hyperplasia in the lungs of male and female rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			9x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloral_hydrate_137' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=304'>Chloral hydrate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000302170'>302-17-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			CNS depression and GI irritation in humans 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloramben_138' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=23'>Chloramben</a> 
		</td>
	
		<td>
			<span id='sortby_000000000133904'>133-90-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatocyte degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlordane_(Technical)_139' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=142'>Chlordane (Technical)</a> 
		</td>
	
		<td>
			<span id='sortby_000000012789036'>12789-03-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlordane_(Technical)_140' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=142'>Chlordane (Technical)</a> 
		</td>
	
		<td>
			<span id='sortby_000000012789036'>12789-03-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlordane_(Technical)_141' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=142'>Chlordane (Technical)</a> 
		</td>
	
		<td>
			<span id='sortby_000000012789036'>12789-03-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3.5x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlordane_(Technical)_142' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=142'>Chlordane (Technical)</a> 
		</td>
	
		<td>
			<span id='sortby_000000012789036'>12789-03-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic necrosis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlordecone_(Kepone)_143' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1017'>Chlordecone (Kepone)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000143500'>143-50-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal lesions (glomerulosclerosis) in female Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlordecone_(Kepone)_144' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1017'>Chlordecone (Kepone)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000143500'>143-50-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			liver hepatocellular carcinoma 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1x10<sup>1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorimuron-ethyl_145' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=406'>Chlorimuron-ethyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000090982324'>90982-32-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increase in WBC, decreased in RBC in females, increase in alkaline phosphatase in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorine_146' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=405'>Chlorine</a> 
		</td>
	
		<td>
			<span id='sortby_000000007782505'>7782-50-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No observed adverse effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorine_cyanide_147' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=24'>Chlorine cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000506774'>506-77-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Weight loss, thyroid effects, and myelin degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorine_dioxide_148' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=496'>Chlorine dioxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000010049044'>10049-04-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Vascular congestion and peribronchial edema 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorine_dioxide_149' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=496'>Chlorine dioxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000010049044'>10049-04-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurodevelopmental effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorite_(sodium_salt)_150' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=648'>Chlorite (sodium salt)</a> 
		</td>
	
		<td>
			<span id='sortby_000000007758192'>7758-19-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurodevelopmental effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloro-1,1-difluoroethane_151' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=661'>1-Chloro-1,1-difluoroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075683'>75-68-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloroacetophenone_152' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=537'>2-Chloroacetophenone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000532274'>532-27-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Squamous hyperplasia of the nasal respiratory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-5</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloroaniline_153' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=320'>p-Chloroaniline</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106478'>106-47-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nonneoplastic lesions of splenic capsule 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorobenzene_154' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=399'>Chlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108907'>108-90-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Histopathologic changes in liver 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorobenzilate_155' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=400'>Chlorobenzilate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000510156'>510-15-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased stool quantity, food consumption and body weight gains hyperirritability (maternal effects) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorodifluoromethane_156' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=657'>Chlorodifluoromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075456'>75-45-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased kidney, adrenal and pituitary weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloroform_157' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=25'>Chloroform</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067663'>67-66-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Likely to be carcinogenic to humans (1999 guidelines)  Not likely to be carcinogenic to humans (1999 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.3x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloroform_158' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=25'>Chloroform</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067663'>67-66-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Moderate/marked fatty cyst formation in the liver and elevated SGPT 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloronaphthalene_159' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=463'>beta-Chloronaphthalene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000091587'>91-58-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Dyspnea, abnormal appearance, liver enlargement 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorophenol_160' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=303'>2-Chlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095578'>95-57-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reproductive effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloroprene_161' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1021'>Chloroprene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000126998'>126-99-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			alveolar/ bronchiolar adenoma or carcinoma hemangioma/ hemangiosarcoma (all organs) mammary gland adenocarcinoma, carcinoma, or adenoacanthoma forestomach squamous cell papilloma or carcinoma hepatocellular adenoma or carcinoma Harderian gland adenoma or carcinoma skin sarcoma and Zymbal's gland carcinoma 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chloroprene_162' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1021'>Chloroprene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000126998'>126-99-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increase in incidence of olfactory atrophy, alveolar hyperplasia, and splenic hematopoietic proliferation in male F344/N rats, female F344/N rats, and female B6C3F1 mice, respectively 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorothalonil_163' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=143'>Chlorothalonil</a> 
		</td>
	
		<td>
			<span id='sortby_000000001897456'>1897-45-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal tubular epithelial vacuolation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorotoluene_164' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=412'>o-Chlorotoluene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095498'>95-49-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decrease in body weight gain 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorpropham_165' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=283'>Chlorpropham</a> 
		</td>
	
		<td>
			<span id='sortby_000000000101213'>101-21-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney, spleen, liver, and bone marrow toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chlorsulfuron_166' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=27'>Chlorsulfuron</a> 
		</td>
	
		<td>
			<span id='sortby_000000064902723'>64902-72-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chromium(III),_insoluble_salts_167' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=28'>Chromium(III), insoluble salts</a> 
		</td>
	
		<td>
			<span id='sortby_000000016065831'>16065-83-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No effects observed 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chromium(VI)_168' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=144'>Chromium(VI)</a> 
		</td>
	
		<td>
			<span id='sortby_000000018540299'>18540-29-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung cancer 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Carcinogenic potential cannot be determined (1996 guidelines)  D (Not classifiable as to human carcinogenicity) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.2x10<sup>-2</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chromium(VI)_169' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=144'>Chromium(VI)</a> 
		</td>
	
		<td>
			<span id='sortby_000000018540299'>18540-29-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			None reported 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chromium(VI)_170' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=144'>Chromium(VI)</a> 
		</td>
	
		<td>
			<span id='sortby_000000018540299'>18540-29-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Lactate dehydrogenase in bronchioalveolar lavage fluid 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/m<sup>3</sup> (Cr(VI) particulates) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Chromium(VI)_171' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=144'>Chromium(VI)</a> 
		</td>
	
		<td>
			<span id='sortby_000000018540299'>18540-29-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nasal septum atrophy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			8x10<sup>-6</sup> mg/m<sup>3</sup> (Chromic acid mists and dissolved Cr(VI) aerosols) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Coke_oven_emissions_172' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=395'>Coke oven emissions</a> 
		</td>
	
		<td>
			<span id='sortby_000000000000000'></span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Respiratory cancer 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6.2x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Copper_cyanide_173' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=29'>Copper cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000544923'>544-92-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body and organ weights, histopathologic alterations in liver and kidney 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cumene_174' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=306'>Cumene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098828'>98-82-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased average kidney weight in female rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cumene_175' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=306'>Cumene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098828'>98-82-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased kidney weights in female rats and adrenal weights in male and female rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyanide,_free_176' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=31'>Cyanide, free</a> 
		</td>
	
		<td>
			<span id='sortby_000000000057125'>57-12-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased cauda epididymis weight in male F344/N rats. The RfD for cyanide, free is presented in section 1.A.3 of the hydrogen cyanide and cyanide salts IRIS Summary. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6.3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyanogen_177' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=32'>Cyanogen</a> 
		</td>
	
		<td>
			<span id='sortby_000000000460195'>460-19-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased cauda epididymis weight in male F344/N rats. The RfD for cyanogen is presented in section I.A.3 of the hydrogen cyanide and cyanide salts IRIS Summary. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyanogen_bromide_178' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=358'>Cyanogen bromide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000506683'>506-68-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Weight loss, thyroid effects and myelin degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyclohexane_179' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1005'>Cyclohexane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000110827'>110-82-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced pup weights in the F1 and F2 generations 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyclohexanone_180' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=219'>Cyclohexanone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108941'>108-94-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Body weight depression 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyclohexylamine_181' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=319'>Cyclohexylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108918'>108-91-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Testicular damage 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyhalothrin/Karate_182' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=279'>Cyhalothrin/Karate</a> 
		</td>
	
		<td>
			<span id='sortby_000000068085858'>68085-85-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight gain preceding pregnancy reduced body weight gain in offspring during weaning period 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cypermethrin_183' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=380'>Cypermethrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000052315078'>52315-07-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			G.I. tract disturbances 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Cyromazine_184' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=220'>Cyromazine</a> 
		</td>
	
		<td>
			<span id='sortby_000000066215278'>66215-27-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hematologic effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7.5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dacthal_185' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=221'>Dacthal</a> 
		</td>
	
		<td>
			<span id='sortby_000000001861321'>1861-32-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Effects on the lungs, liver, kidney, thyroid and thyroid hormones in males and females and eyes of females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dalapon,_sodium_salt_186' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=146'>Dalapon, sodium salt</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075990'>75-99-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased kidney body weight ratio 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Danitol_187' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=34'>Danitol</a> 
		</td>
	
		<td>
			<span id='sortby_000000039515418'>39515-41-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Tremors 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Decabromodiphenyl_ether_(BDE-209)_188' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=35'>2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether (BDE-209)</a> 
		</td>
	
		<td>
			<span id='sortby_000000001163195'>1163-19-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurobehavioral effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Decabromodiphenyl_ether_(BDE-209)_189' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=35'>2,2',3,3',4,4',5,5',6,6'-Decabromodiphenyl ether (BDE-209)</a> 
		</td>
	
		<td>
			<span id='sortby_000000001163195'>1163-19-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver neoplastic nodules or carcinoma (combined) 
		</td>
	
		<td>
			Suggestive evidence of carcinogenic potential (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7x10<sup>-4</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Demeton_190' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=36'>Demeton</a> 
		</td>
	
		<td>
			<span id='sortby_000000008065483'>8065-48-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			ChE inhibition, optic nerve degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Di_(2-ethylhexyl)phthalate_(DEHP)_191' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=14'>Di (2-ethylhexyl)phthalate (DEHP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000117817'>117-81-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased relative liver weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Di_(2-ethylhexyl)phthalate_(DEHP)_192' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=14'>Di (2-ethylhexyl)phthalate (DEHP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000117817'>117-81-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma and adenoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.4x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Di(2-ethylhexyl)adipate_193' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=420'>Di(2-ethylhexyl)adipate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000103231'>103-23-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Changes in body weight and liver weight increased liver weight of male and female parents reduced ossification and slightly dilated ureters in fetuses reduced offspring weight gain, total litter weight, and litter size 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Di(2-ethylhexyl)adipate_194' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=420'>Di(2-ethylhexyl)adipate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000103231'>103-23-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Combined hepatocellular adenomas and carcinomas 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.2x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromo-3-chloropropane_(DBCP)_195' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=414'>1,2-Dibromo-3-chloropropane (DBCP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000096128'>96-12-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Testicular effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromobenzene_196' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=148'>1,4-Dibromobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106376'>106-37-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver/body weight ratio and hepatic microsomal enzyme induction 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromochloromethane_197' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=222'>Dibromochloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000124481'>124-48-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromochloromethane_198' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=222'>Dibromochloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000124481'>124-48-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenoma or carcinoma 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			8.4x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromoethane_199' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=361'>1,2-Dibromoethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106934'>106-93-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Forestomach tumors, hemangiosarcomas, thyroid follicular cell adenomas or carcinomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (1999 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1  mg/kg-day </br>(central tendency estimate) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromoethane_200' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=361'>1,2-Dibromoethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106934'>106-93-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Forestomach tumors, hemangiosarcomas, thyroid follicular cell adenomas or carcinomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (1999 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2  per mg/kg-day </br>(95% upper bound) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromoethane_201' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=361'>1,2-Dibromoethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106934'>106-93-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Nasal cavity (includes adenoma, adenocarcinoma, papillary adenoma, squamous cell carcinoma, and or/papilloma), hemangiosarcomas, mesotheliomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (1999 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br>(95% upper bound) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromoethane_202' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=361'>1,2-Dibromoethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106934'>106-93-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Nasal cavity (includes adenoma, adenocarcinoma, papillary adenoma, squamous cell carcinoma, and or/papilloma), hemangiosarcomas, mesotheliomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (1999 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br>(central tendency estimate) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromoethane_203' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=361'>1,2-Dibromoethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106934'>106-93-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Testicular atrophy, liver peliosis, and adrenal cortical degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibromoethane_204' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=361'>1,2-Dibromoethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106934'>106-93-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nasal inflammation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dibutyl_phthalate_(DBP)_205' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=38'>Dibutyl phthalate (DBP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000084742'>84-74-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased mortality 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dicamba_206' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=223'>Dicamba</a> 
		</td>
	
		<td>
			<span id='sortby_000000001918009'>1918-00-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Maternal (reduced weight gain) and fetal toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroacetic_acid_207' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=654'>Dichloroacetic acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079436'>79-43-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Lesions observed in the testes, cerebrum, cerebellum, and liver. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroacetic_acid_208' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=654'>Dichloroacetic acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079436'>79-43-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatoadenoma and Hepatocarcinoma 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (1999 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorobenzene_209' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=408'>1,2-Dichlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095501'>95-50-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects observed 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorobenzene_210' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=552'>1,4-Dichlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106467'>106-46-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver weights in P1 males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			8x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorobenzidine_211' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=504'>3,3'-Dichlorobenzidine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000091941'>91-94-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Mammary adenocarcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			4.5x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorodifluoromethane_212' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=40'>Dichlorodifluoromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075718'>75-71-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorodiphenyl_dichloroethane_(DDD)_213' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=347'>p,p'-Dichlorodiphenyl dichloroethane (DDD)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000072548'>72-54-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.4x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorodiphenyldichloroethylene_(DDE)_214' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=328'>p,p'-Dichlorodiphenyldichloroethylene (DDE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000072559'>72-55-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas, hepatomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3.4x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorodiphenyltrichloroethane_(DDT)_215' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=147'>p,p'-Dichlorodiphenyltrichloroethane (DDT)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050293'>50-29-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors, benign and malignant 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			9.7x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorodiphenyltrichloroethane_(DDT)_216' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=147'>p,p'-Dichlorodiphenyltrichloroethane (DDT)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050293'>50-29-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors, benign and malignant 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3.4x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorodiphenyltrichloroethane_(DDT)_217' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=147'>p,p'-Dichlorodiphenyltrichloroethane (DDT)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050293'>50-29-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroethane_218' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=149'>1,2-Dichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107062'>107-06-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hemangiosarcomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			9.1x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroethane_219' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=149'>1,2-Dichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107062'>107-06-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hemangiosarcomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.6x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroethylene_220' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=418'>cis-1,2-Dichloroethylene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000156592'>156-59-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased relative kidney weight in male rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroethylene_221' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=314'>trans-1,2-Dichloroethylene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000156605'>156-60-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decrease in number of antibody forming cells (AFCs) against sheep red blood cells (sRBCs) in male mice 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroethylene_(1,1-DCE)_222' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=39'>1,1-Dichloroethylene (1,1-DCE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075354'>75-35-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver toxicity (fatty change) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloroethylene_(1,1-DCE)_223' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=39'>1,1-Dichloroethylene (1,1-DCE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075354'>75-35-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver toxicity (fatty change) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloromethane_224' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=70'>Dichloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075092'>75-09-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas or adenomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloromethane_225' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=70'>Dichloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075092'>75-09-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic effects (hepatic vacuolation, liver foci) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloromethane_226' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=70'>Dichloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075092'>75-09-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas or adenomas, bronchoalveolar carcinomas or adenomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1x10<sup>-8</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloromethane_227' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=70'>Dichloromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075092'>75-09-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic effects (hepatic vacuolation) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorophenol_228' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=41'>2,4-Dichlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000120832'>120-83-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased delayed hypersensitivity response 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorophenoxy)butyric_acid_(2,4-DB)_229' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=33'>4-(2,4-Dichlorophenoxy)butyric acid (2,4-DB)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000094826'>94-82-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Internal hemorrhage, mortality 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorophenoxyacetic_acid_(2,4-D)_230' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=150'>2,4-Dichlorophenoxyacetic acid (2,4-D)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000094757'>94-75-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hematologic, hepatic and renal toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropane_231' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=601'>1,2-Dichloropropane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078875'>78-87-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hyperplasia of the nasal mucosa 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropanol_232' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=465'>2,3-Dichloropropanol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000616239'>616-23-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Myocardial degeneration, hepatotoxicity and nephrotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropene_233' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=224'>1,3-Dichloropropene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542756'>542-75-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenoma/carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropene_234' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=224'>1,3-Dichloropropene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542756'>542-75-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Urinary bladder carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropene_235' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=224'>1,3-Dichloropropene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542756'>542-75-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Bronchioalveolar adenoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropene_236' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=224'>1,3-Dichloropropene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542756'>542-75-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenoma/carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropene_237' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=224'>1,3-Dichloropropene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542756'>542-75-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hypertrophy/ hyperplasia of the nasal respiratory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichloropropene_238' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=224'>1,3-Dichloropropene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000542756'>542-75-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Chronic irritation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorvos_239' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=151'>Dichlorvos</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062737'>62-73-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Plasma and RBC ChE inhibition in males and females brain ChE inhibition in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorvos_240' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=151'>Dichlorvos</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062737'>62-73-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Forestomach tumors, pancreatic acinar adenoma, leukemia 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.9x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dichlorvos_241' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=151'>Dichlorvos</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062737'>62-73-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased brain cholinesterase activity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dieldrin_242' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=225'>Dieldrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000060571'>60-57-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dieldrin_243' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=225'>Dieldrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000060571'>60-57-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.6x10<sup>1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dieldrin_244' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=225'>Dieldrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000060571'>60-57-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.6x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diesel_engine_exhaust_245' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=642'>Diesel engine exhaust</a> 
		</td>
	
		<td>
			<span id='sortby_000000000000000'></span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Pulmonary inflammation and histopathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diethyl_phthalate_(DEP)_246' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=226'>Diethyl phthalate (DEP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000084662'>84-66-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased growth rate, food consumption and altered organ weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Difenzoquat_247' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=336'>Difenzoquat</a> 
		</td>
	
		<td>
			<span id='sortby_000000043222486'>43222-48-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diflubenzuron_248' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=227'>Diflubenzuron</a> 
		</td>
	
		<td>
			<span id='sortby_000000035367385'>35367-38-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Methemoglobin and sulfhemoglobin formation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Difluoroethane_249' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=665'>1,1-Difluoroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075376'>75-37-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects observed 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4x10<sup>1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diisopropyl_methylphosphonate_(DIMP)_250' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=310'>Diisopropyl methylphosphonate (DIMP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000001445756'>1445-75-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No effects related to treatment 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethipin_251' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=43'>Dimethipin</a> 
		</td>
	
		<td>
			<span id='sortby_000000055290647'>55290-64-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute and relative liver weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethoate_252' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=44'>Dimethoate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000060515'>60-51-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Brain ChE inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethyl_terephthalate_(DMT)_253' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=46'>Dimethyl terephthalate (DMT)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000120616'>120-61-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Chronic kidney inflammation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethylaniline_254' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=229'>N-N-Dimethylaniline</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121697'>121-69-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Splenomegaly, increased splenic hemosiderosis and hematopoiesis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethylformamide_255' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=511'>N,N-Dimethylformamide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000068122'>68-12-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Digestive disturbances and minimal hepatic changes suggestive of liver abnormalities 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethylphenol_256' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=466'>2,4-Dimethylphenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000105679'>105-67-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Clinical signs (lethargy, prostration, and ataxia) and hematological changes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethylphenol_257' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=230'>2,6-Dimethylphenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000576261'>576-26-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Body weight changes and histopathological changes of internal organs (liver, spleen and kidneys) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dimethylphenol_258' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=231'>3,4-Dimethylphenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095658'>95-65-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Changes in blood pressure and body weight histopathological changes in liver, kidney and spleen 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dinitro-o-cyclohexyl_phenol_259' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=322'>4,6-Dinitro-o-cyclohexyl phenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000131895'>131-89-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Cataract formation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dinitrobenzene_260' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=318'>m-Dinitrobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000099650'>99-65-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased splenic weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dinitrophenol_261' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=152'>2,4-Dinitrophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000051285'>51-28-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Cataract formation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dinitrotoluene_262' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=524'>2,4-Dinitrotoluene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121142'>121-14-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurotoxicity, Heinz bodies and biliary tract hyperplasia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dinitrotoluene_mixture_263' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=397'>2,4-/2,6-Dinitrotoluene mixture</a> 
		</td>
	
		<td>
			<span id='sortby_'>Various</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver: hepatocellular carcinomas, neoplastic nodules; mammary gland: adenomas, fibroadenomas, fibromas, adenocarcinomas/ carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			6.8x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dinoseb_264' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=47'>Dinoseb</a> 
		</td>
	
		<td>
			<span id='sortby_000000000088857'>88-85-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased fetal weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dioxane_265' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=326'>1,4-Dioxane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000123911'>123-91-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Multiple (nasal, liver, kidney, peritoneal, mammary gland, and Zymbal gland) 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			5x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dioxane_266' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=326'>1,4-Dioxane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000123911'>123-91-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Atrophy and respiratory metaplasia of the olfactory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dioxane_267' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=326'>1,4-Dioxane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000123911'>123-91-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenoma and carcinoma 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dioxane_268' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=326'>1,4-Dioxane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000123911'>123-91-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and kidney toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diphenamid_269' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=232'>Diphenamid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000957517'>957-51-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diphenylamine_270' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=48'>Diphenylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000122394'>122-39-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain, and increased liver and kidney weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diphenylhydrazine_271' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=49'>1,2-Diphenylhydrazine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000122667'>122-66-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas and neoplastic liver nodules 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			8.0x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diphenylhydrazine_272' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=49'>1,2-Diphenylhydrazine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000122667'>122-66-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas and neoplastic liver nodules 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.2x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diquat_273' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=153'>Diquat</a> 
		</td>
	
		<td>
			<span id='sortby_000000002764729'>2764-72-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Minimal lens opacity and cataracts 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Disulfoton_274' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=154'>Disulfoton</a> 
		</td>
	
		<td>
			<span id='sortby_000000000298044'>298-04-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			ChE inhibition, optic nerve degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dithiane_275' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=531'>1,4-Dithiane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000505293'>505-29-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nasal olfactory lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Diuron_276' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=233'>Diuron</a> 
		</td>
	
		<td>
			<span id='sortby_000000000330541'>330-54-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Abnormal pigments in blood 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Dodine_277' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=234'>Dodine</a> 
		</td>
	
		<td>
			<span id='sortby_000000002439103'>2439-10-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Thyroid toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Endosulfan_278' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=235'>Endosulfan</a> 
		</td>
	
		<td>
			<span id='sortby_000000000115297'>115-29-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight gain in males and females increased incidence of marked progressive glomerulonephrosis and blood vessel aneurysms in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Endothall_279' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=155'>Endothall</a> 
		</td>
	
		<td>
			<span id='sortby_000000000145733'>145-73-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute and relative weights of stomach and small intestine 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Endrin_280' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=363'>Endrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000072208'>72-20-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mild histological lesions in liver, occasional convulsions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Epichlorohydrin_281' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=50'>Epichlorohydrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106898'>106-89-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Papillomas and carcinomas of the forestomach 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			9.9x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Epichlorohydrin_282' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=50'>Epichlorohydrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106898'>106-89-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Changes in the nasal turbinates 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Epichlorohydrin_283' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=50'>Epichlorohydrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106898'>106-89-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Nasal cavity tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.2x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Epoxybutane_(EBU)_284' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=630'>1,2-Epoxybutane (EBU)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000106887'>106-88-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degenerative lesions of the nasal cavity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethephon_285' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=297'>Ethephon</a> 
		</td>
	
		<td>
			<span id='sortby_000000016672870'>16672-87-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Plasma ChE inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethion_286' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=156'>Ethion</a> 
		</td>
	
		<td>
			<span id='sortby_000000000563122'>563-12-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Plasma cholinesterase inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethoxyethanol_287' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=513'>2-Ethoxyethanol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000110805'>110-80-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased testis weight, seminiferous tubule degeneration and decreased hemoglobin 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_Tertiary_Butyl_Ether_(ETBE)_288' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1034'>Ethyl Tertiary Butyl Ether (ETBE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000637923'>637-92-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute kidney weight in female rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_Tertiary_Butyl_Ether_(ETBE)_289' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1034'>Ethyl Tertiary Butyl Ether (ETBE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000637923'>637-92-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute kidney weight in female rats

		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4x10<sup>1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_Tertiary_Butyl_Ether_(ETBE)_290' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1034'>Ethyl Tertiary Butyl Ether (ETBE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000637923'>637-92-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenomas and carcinomas 
		</td>
	
		<td>
			Suggestive evidence of carcinogenic potential (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			8x10<sup>-5</sup>  per mg/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_acetate_291' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=157'>Ethyl acetate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000141786'>141-78-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mortality and body weight loss 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_chloride_292' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=523'>Ethyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075003'>75-00-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Delayed fetal ossification 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_dipropylthiocarbamate_(EPTC)_293' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=237'>S-Ethyl dipropylthiocarbamate (EPTC)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000759944'>759-94-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degenerative cardiomyopathy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_ether_294' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=423'>Ethyl ether</a> 
		</td>
	
		<td>
			<span id='sortby_000000000060297'>60-29-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Depressed body weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethyl_p-nitrophenyl_phenylphosphorothioate_(EPN)_295' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=236'>Ethyl p-nitrophenyl phenylphosphorothioate (EPN)</a> 
		</td>
	
		<td>
			<span id='sortby_000000002104645'>2104-64-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylbenzene_296' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=51'>Ethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000100414'>100-41-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and kidney toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylbenzene_297' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=51'>Ethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000100414'>100-41-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Developmental toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylene_glycol_298' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=238'>Ethylene glycol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107211'>107-21-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylene_glycol_monobutyl_ether_(EGBE)_(2-Butoxyethanol)_299' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=500'>Ethylene glycol monobutyl ether (EGBE) (2-Butoxyethanol)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000111762'>111-76-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hemosiderin deposition in the liver 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylene_glycol_monobutyl_ether_(EGBE)_(2-Butoxyethanol)_300' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=500'>Ethylene glycol monobutyl ether (EGBE) (2-Butoxyethanol)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000111762'>111-76-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hemosiderin deposition in the liver 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1.6 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylene_oxide_301' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1025'>Ethylene oxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075218'>75-21-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lymphoid cancer, (female) breast cancer 
		</td>
	
		<td>
			Carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylene_thiourea_(ETU)_302' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=239'>Ethylene thiourea (ETU)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000096457'>96-45-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased incidence of thyroid hyperplasia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Ethylphthalyl_ethylglycolate_(EPEG)_303' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=52'>Ethylphthalyl ethylglycolate (EPEG)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000084720'>84-72-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney damage and reduced lifespan 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Express_304' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=379'>Express</a> 
		</td>
	
		<td>
			<span id='sortby_000000101200480'>101200-48-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Elevated serum bilirubin and AST levels, increased urinary volume 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fenamiphos_305' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=240'>Fenamiphos</a> 
		</td>
	
		<td>
			<span id='sortby_000000022224926'>22224-92-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			ChE inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fluometuron_306' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=241'>Fluometuron</a> 
		</td>
	
		<td>
			<span id='sortby_000000002164172'>2164-17-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fluoranthene_307' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=444'>Fluoranthene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000206440'>206-44-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nephropathy, increased liver weights, hematological alterations, and clinical effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fluorene_308' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=435'>Fluorene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000086737'>86-73-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased RBC, packed cell volume and hemoglobin 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fluorine_(soluble_fluoride)_309' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=53'>Fluorine (soluble fluoride)</a> 
		</td>
	
		<td>
			<span id='sortby_000000007782414'>7782-41-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Objectionable dental fluorosis, a cosmetic effect 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fluridone_310' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=54'>Fluridone</a> 
		</td>
	
		<td>
			<span id='sortby_000000059756604'>59756-60-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Glomerulonephritis, atrophic testes, eye keratitis decreased body weight and organ weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Flurprimidol_311' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=383'>Flurprimidol</a> 
		</td>
	
		<td>
			<span id='sortby_000000056425913'>56425-91-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased incidence of hepatocellular changes including fatty change and vacuolation (M) increased susceptibility to stress factors (F) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Flutolanil_312' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=394'>Flutolanil</a> 
		</td>
	
		<td>
			<span id='sortby_000000066332965'>66332-96-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight and body weight gains in both doses increased liver weights at high dose 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fluvalinate_313' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=281'>Fluvalinate</a> 
		</td>
	
		<td>
			<span id='sortby_000000069409945'>69409-94-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreases in body weight gain increase in plantar ulcer (females) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Folpet_314' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=242'>Folpet</a> 
		</td>
	
		<td>
			<span id='sortby_000000000133073'>133-07-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain, altered serum chemistry parameters (decreased serum cholesterol, total protein, and serum albumin and globulin levels) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fonofos_315' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=158'>Fonofos</a> 
		</td>
	
		<td>
			<span id='sortby_000000000944229'>944-22-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Cholinesterase inhibition, cholinergic symptoms, and increased liver weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Formaldehyde_316' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=419'>Formaldehyde</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050000'>50-00-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Squamous cell carcinoma 
		</td>
	
		<td>
			B1 (Probable human carcinogen - based on limited evidence of carcinogenicity in humans) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.3x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Formaldehyde_317' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=419'>Formaldehyde</a> 
		</td>
	
		<td>
			<span id='sortby_000000000050000'>50-00-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced weight gain, histopathology in rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Fosetyl-al_318' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=159'>Fosetyl-al</a> 
		</td>
	
		<td>
			<span id='sortby_000000039148248'>39148-24-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Slight testicular degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Furan_319' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=56'>Furan</a> 
		</td>
	
		<td>
			<span id='sortby_000000000110009'>110-00-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Furfural_320' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=317'>Furfural</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098011'>98-01-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mild hepatocellular vacuolization 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Furmecyclox_321' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=362'>Furmecyclox</a> 
		</td>
	
		<td>
			<span id='sortby_000000060568050'>60568-05-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Combined liver nodules and carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3.0x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Glufosinate-ammonium_322' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=247'>Glufosinate-ammonium</a> 
		</td>
	
		<td>
			<span id='sortby_000000077182822'>77182-82-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute and relative kidney weights in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Glycidaldehyde_323' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=315'>Glycidaldehyde</a> 
		</td>
	
		<td>
			<span id='sortby_000000000765344'>765-34-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Weight gain retardation, enlarged adrenals, hydropic renal pelvis and hematopoietic effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Glyphosate_324' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=57'>Glyphosate</a> 
		</td>
	
		<td>
			<span id='sortby_000000001071836'>1071-83-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased incidence of renal tubular dilation in F3b offspring 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Haloxyfop-methyl_325' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=467'>Haloxyfop-methyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000069806402'>69806-40-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced relative kidney weights in F0, F1, and F2b adults; reduced fertility in the F1/F2b generation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Harmony_326' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=337'>Harmony</a> 
		</td>
	
		<td>
			<span id='sortby_000000079277273'>79277-27-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight gains in males, reduced serum sodium in males and females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Heptachlor_327' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=243'>Heptachlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000000076448'>76-44-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			4.5  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Heptachlor_328' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=243'>Heptachlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000000076448'>76-44-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver weight increases in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Heptachlor_329' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=243'>Heptachlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000000076448'>76-44-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.3x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Heptachlor_epoxide_330' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=160'>Heptachlor epoxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000001024573'>1024-57-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver-to-body weight ratio in both males and females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Heptachlor_epoxide_331' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=160'>Heptachlor epoxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000001024573'>1024-57-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			9.1  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Heptachlor_epoxide_332' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=160'>Heptachlor epoxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000001024573'>1024-57-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.6x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexabromobenzene_333' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=161'>Hexabromobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000087821'>87-82-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Induced serum carboxylesterase activity, increased relative liver weight, increased liver porphyrins 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexabromodiphenyl_ether_(BDE-153)_334' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1009'>2,2',4,4',5,5'-Hexabromodiphenyl ether (BDE-153)</a> 
		</td>
	
		<td>
			<span id='sortby_000000068631492'>68631-49-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurobehavioral effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorobenzene_335' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=374'>Hexachlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000118741'>118-74-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.6x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorobenzene_336' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=374'>Hexachlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000118741'>118-74-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorobenzene_337' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=374'>Hexachlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000118741'>118-74-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.6  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorobutadiene_338' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=58'>Hexachlorobutadiene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000087683'>87-68-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Renal tubular adenomas and adenocarcinomas 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.2x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorobutadiene_339' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=58'>Hexachlorobutadiene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000087683'>87-68-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Renal tubular adenomas and adenocarcinomas 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7.8x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclohexane_(alpha-HCH)_340' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=162'>alpha-Hexachlorocyclohexane (alpha-HCH)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000319846'>319-84-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatic nodules and hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.8x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclohexane_(alpha-HCH)_341' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=162'>alpha-Hexachlorocyclohexane (alpha-HCH)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000319846'>319-84-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatic nodules and hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			6.3  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclohexane_(beta-HCH)_342' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=244'>beta-Hexachlorocyclohexane (beta-HCH)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000319857'>319-85-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatic nodules and hepatocellular carcinomas 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			5.3x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclohexane_(beta-HCH)_343' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=244'>beta-Hexachlorocyclohexane (beta-HCH)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000319857'>319-85-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatic nodules and hepatocellular carcinomas 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.8  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclohexane_(gamma-HCH)_344' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=65'>gamma-Hexachlorocyclohexane (gamma-HCH)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000058899'>58-89-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and kidney toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclohexane_(t-HCH)_345' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=165'>technical Hexachlorocyclohexane (t-HCH)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000608731'>608-73-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver nodules and hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.8  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclohexane_(t-HCH)_346' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=165'>technical Hexachlorocyclohexane (t-HCH)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000608731'>608-73-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver nodules and hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			5.1x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclopentadiene_(HCCPD)_347' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=59'>Hexachlorocyclopentadiene (HCCPD)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000077474'>77-47-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Chronic irritation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorocyclopentadiene_(HCCPD)_348' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=59'>Hexachlorocyclopentadiene (HCCPD)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000077474'>77-47-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Suppurative inflammation of the nose 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorodibenzo-p-dioxin_(HxCDD),_mixture_of_1,2,3,6,7,8-HxCDD_and_1,2,3,7,8,9-HxCDD_349' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=166'>Hexachlorodibenzo-p-dioxin (HxCDD), mixture of 1,2,3,6,7,8-HxCDD and 1,2,3,7,8,9-HxCDD</a> 
		</td>
	
		<td>
			<span id='sortby_000000057653857'>57653-85-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors (adenomas and carcinomas; neoplastic nodules and hepatocellular carcinomas) 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			6.2x10<sup>3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorodibenzo-p-dioxin_(HxCDD),_mixture_of_1,2,3,6,7,8-HxCDD_and_1,2,3,7,8,9-HxCDD_350' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=166'>Hexachlorodibenzo-p-dioxin (HxCDD), mixture of 1,2,3,6,7,8-HxCDD and 1,2,3,7,8,9-HxCDD</a> 
		</td>
	
		<td>
			<span id='sortby_000000057653857'>57653-85-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors (adenomas and carcinomas; neoplastic nodules and hepatocellular carcinomas) 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.3  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachloroethane_351' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=167'>Hexachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067721'>67-72-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Atrophy and degeneration of renal tubules 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachloroethane_352' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=167'>Hexachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067721'>67-72-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurotoxicity (tremors and ruffled pelt) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachloroethane_353' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=167'>Hexachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067721'>67-72-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Renal adenomas and carcinomas (combined) 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			4x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexachlorophene_354' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=338'>Hexachlorophene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000070304'>70-30-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Swollen salivary glands, status spongiosis in brain and optic nerve 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexahydro-1,3,5-trinitro-1,3,5-triazine_(RDX)_355' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=313'>Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121824'>121-82-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Suppurative prostatitis in F344 rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexahydro-1,3,5-trinitro-1,3,5-triazine_(RDX)_356' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=313'>Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121824'>121-82-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver (hepatocellular adenomas or carcinomas) and lung (alveolar/bronchiolar adenomas or carcinomas) 
		</td>
	
		<td>
			Suggestive evidence of carcinogenic potential (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			8x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexahydro-1,3,5-trinitro-1,3,5-triazine_(RDX)_357' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=313'>Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121824'>121-82-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Convulsions in F344 rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexahydro-1,3,5-trinitro-1,3,5-triazine_(RDX)_358' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=313'>Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121824'>121-82-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney medullary papillary necrosis in F344 rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexamethylene_diisocyanate_359' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=638'>1,6-Hexamethylene diisocyanate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000822060'>822-06-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degeneration of olfactory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-5</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexane_360' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=486'>n-Hexane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000110543'>110-54-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Peripheral neuropathy (decreased MCV at 12 weeks) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexanone_361' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1019'>2-Hexanone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000591786'>591-78-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Motor conduction velocity of the sciatic-tibial nerve 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexanone_362' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1019'>2-Hexanone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000591786'>591-78-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Axonal swelling of the peripheral nerve 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hexazinone_363' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=246'>Hexazinone</a> 
		</td>
	
		<td>
			<span id='sortby_000000051235042'>51235-04-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hydrazine/Hydrazine_sulfate_364' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=352'>Hydrazine/Hydrazine sulfate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000302012'>302-01-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3.0  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hydrazine/Hydrazine_sulfate_365' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=352'>Hydrazine/Hydrazine sulfate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000302012'>302-01-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Nasal cavity adenoma or adenocarcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.9x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hydrogen_Cyanide_and_Cyanide_Salts_366' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=60'>Hydrogen Cyanide and Cyanide Salts</a> 
		</td>
	
		<td>
			<span id='sortby_'>Various</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased cauda epididymis weight in male F344/N rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hydrogen_Cyanide_and_Cyanide_Salts_367' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=60'>Hydrogen Cyanide and Cyanide Salts</a> 
		</td>
	
		<td>
			<span id='sortby_'>Various</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Thyroid enlargement and altered iodide uptake 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			8x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hydrogen_chloride_368' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=396'>Hydrogen chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000007647010'>7647-01-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hyperplasia of nasal mucosa larynx and trachea 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Hydrogen_sulfide_369' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=61'>Hydrogen sulfide</a> 
		</td>
	
		<td>
			<span id='sortby_000000007783064'>7783-06-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nasal lesions of the olfactory mucosa 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Imazalil_370' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=168'>Imazalil</a> 
		</td>
	
		<td>
			<span id='sortby_000000035554440'>35554-44-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Imazaquin_371' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=62'>Imazaquin</a> 
		</td>
	
		<td>
			<span id='sortby_000000081335377'>81335-37-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain, skeletal myopathy, slight anemia, bone marrow hyperplasia, elevated serum SGOT, SGPT, CPK 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Iprodione_372' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=291'>Iprodione</a> 
		</td>
	
		<td>
			<span id='sortby_000000036734197'>36734-19-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased RBC Heinz bodies; decreased prostate weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Isobutyl_alcohol_373' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=169'>Isobutyl alcohol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078831'>78-83-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hypoactivity and ataxia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Isophorone_374' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=63'>Isophorone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078591'>78-59-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Preputial gland carcinoma 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			9.5x10<sup>-4</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Isophorone_375' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=63'>Isophorone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078591'>78-59-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney pathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Isopropalin_376' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=64'>Isopropalin</a> 
		</td>
	
		<td>
			<span id='sortby_000000033820530'>33820-53-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced hemoglobin concentration, lowered hematocrits, and altered organ weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Isopropyl_methyl_phosphonic_acid_(IMPA)_377' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=530'>Isopropyl methyl phosphonic acid (IMPA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000001832548'>1832-54-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects observed 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Isoxaben_378' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=339'>Isoxaben</a> 
		</td>
	
		<td>
			<span id='sortby_000000082558507'>82558-50-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased BUN; decreased serum AP and AST; decreased food consumption efficiency; increased heart/body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Lactofen_379' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=280'>Lactofen</a> 
		</td>
	
		<td>
			<span id='sortby_000000077501634'>77501-63-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute and relative liver weight; hepatocytomegaly in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Libby_Amphibole_Asbestos_380' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1026'>Libby Amphibole Asbestos</a> 
		</td>
	
		<td>
			<span id='sortby_000000001318098'>1318-09-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Localized pleural thickening 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			9x10<sup>-5</sup> fiber/cc 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Libby_Amphibole_Asbestos_381' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1026'>Libby Amphibole Asbestos</a> 
		</td>
	
		<td>
			<span id='sortby_000000001318098'>1318-09-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Cancer mortality from lung cancer and mesothelioma 
		</td>
	
		<td>
			Carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.7x10<sup>-1</sup>  per fiber/cc </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Linuron_382' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=170'>Linuron</a> 
		</td>
	
		<td>
			<span id='sortby_000000000330552'>330-55-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Abnormal blood pigment 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Londax_383' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=171'>Londax</a> 
		</td>
	
		<td>
			<span id='sortby_000000083055996'>83055-99-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Malathion_384' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=248'>Malathion</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121755'>121-75-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			RBC ChE depression 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Maleic_anhydride_385' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=307'>Maleic anhydride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108316'>108-31-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Maleic_hydrazide_386' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=172'>Maleic hydrazide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000123331'>123-33-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal dysfunction 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Maneb_387' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=249'>Maneb</a> 
		</td>
	
		<td>
			<span id='sortby_000000012427382'>12427-38-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased thyroid weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Manganese_388' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=373'>Manganese</a> 
		</td>
	
		<td>
			<span id='sortby_000000007439965'>7439-96-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			CNS effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.4x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Manganese_389' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=373'>Manganese</a> 
		</td>
	
		<td>
			<span id='sortby_000000007439965'>7439-96-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Impairment of neurobehavioral function 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5x10<sup>-5</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Mepiquat_chloride_390' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=340'>Mepiquat chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000024307264'>24307-26-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Sedation and tonoclonic spasms decreased food intake and body weights hematologic effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Mercuric_chloride_(HgCl2)_391' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=692'>Mercuric chloride (HgCl2)</a> 
		</td>
	
		<td>
			<span id='sortby_000000007487947'>7487-94-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Autoimmune effects (autoimmune glomerulonephritis) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Mercury,_elemental_392' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=370'>Mercury, elemental</a> 
		</td>
	
		<td>
			<span id='sortby_000000007439976'>7439-97-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hand tremor; increases in memory disturbances; slight subjective and objective evidence of autonomic dysfunction 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Merphos_393' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=366'>Merphos</a> 
		</td>
	
		<td>
			<span id='sortby_000000000150505'>150-50-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Ataxia, delayed neurotoxicity and weight loss 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Merphos_oxide_394' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=367'>Merphos oxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078488'>78-48-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Ataxia, delayed neurotoxicity and weight loss 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Metalaxyl_395' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=68'>Metalaxyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000057837191'>57837-19-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased serum alkaline phosphatase levels and increased liver-to-brain weight ratio 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methacrylonitrile_396' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=359'>Methacrylonitrile</a> 
		</td>
	
		<td>
			<span id='sortby_000000000126987'>126-98-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased SGOT and SGPT levels 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methamidophos_397' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=250'>Methamidophos</a> 
		</td>
	
		<td>
			<span id='sortby_000000010265926'>10265-92-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			ChE inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methanol_398' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=305'>Methanol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067561'>67-56-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Extra cervical ribs 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methanol_399' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=305'>Methanol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000067561'>67-56-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced brain weight in rat pups at 6 weeks of age 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methidathion_400' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=341'>Methidathion</a> 
		</td>
	
		<td>
			<span id='sortby_000000000950378'>950-37-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methomyl_401' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=69'>Methomyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000016752775'>16752-77-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney and spleen pathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methoxychlor_402' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=369'>Methoxychlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000000072435'>72-43-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Excessive loss of litters 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methoxyethanol_403' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=525'>2-Methoxyethanol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000109864'>109-86-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Testicular effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_chloride_404' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1003'>Methyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000074873'>74-87-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Cerebellar lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			9x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_ethyl_ketone_(MEK)_405' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=71'>Methyl ethyl ketone (MEK)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078933'>78-93-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Developmental toxicity (skeletal variations) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_ethyl_ketone_(MEK)_406' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=71'>Methyl ethyl ketone (MEK)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078933'>78-93-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pup body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_isobutyl_ketone_(MIBK)_407' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=173'>Methyl isobutyl ketone (MIBK)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108101'>108-10-1</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced fetal body weight, skeletal variations, and increased fetal death in mice, and skeletal variations in rats. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_methacrylate_408' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1000'>Methyl methacrylate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000080626'>80-62-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Degeneration/ atrophy of olfactory epithelium (male rats) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_methacrylate_409' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1000'>Methyl methacrylate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000080626'>80-62-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			None 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.4 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_parathion_410' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=174'>Methyl parathion</a> 
		</td>
	
		<td>
			<span id='sortby_000000000298000'>298-00-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			RBC, ChE inhibition; reduced hemoglobin, hematocrit and RBCs 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl_tert-butyl_ether_(MTBE)_411' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=545'>Methyl tert-butyl ether (MTBE)</a> 
		</td>
	
		<td>
			<span id='sortby_000000001634044'>1634-04-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute and relative liver and kidney weights and increased severity of spontaneous renal lesions (females), increased prostration (females), and swollen periocular tissue (males and females) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl-4-chlorophenoxy)_butyric_acid_(MCPB)_412' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=325'>4-(2-Methyl-4-chlorophenoxy) butyric acid (MCPB)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000094815'>94-81-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Male reproductive toxicity and other effects (including decreased body weight gain), increased liver and kidney weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl-4-chlorophenoxy)propionic_acid_(MCPP)_413' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=67'>2-(2-Methyl-4-chlorophenoxy)propionic acid (MCPP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000093652'>93-65-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute and relative kidney weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methyl-4-chlorophenoxyacetic_acid_(MCPA)_414' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=66'>2-Methyl-4-chlorophenoxyacetic acid (MCPA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000094746'>94-74-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney and liver toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methylene_Diphenyl_Diisocyanate_(monomeric_MDI)_and_polymeric_MDI_(PMDI)_415' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=529'>Methylene Diphenyl Diisocyanate (monomeric MDI) and polymeric MDI (PMDI)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000101688'>101-68-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hyperplasia of olfactory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methylene_bis(N,N'-dimethyl)aniline_416' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=386'>4,4'-Methylene bis(N,N'-dimethyl)aniline</a> 
		</td>
	
		<td>
			<span id='sortby_000000000101611'>101-61-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Thyroid, follicular cell carcinoma/ adenoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			4.6x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methylmercury_(MeHg)_417' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=73'>Methylmercury (MeHg)</a> 
		</td>
	
		<td>
			<span id='sortby_000000022967926'>22967-92-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Developmental neuropsychological impairment 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/kg-day (High end of BMDL05 range) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methylmercury_(MeHg)_418' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=73'>Methylmercury (MeHg)</a> 
		</td>
	
		<td>
			<span id='sortby_000000022967926'>22967-92-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Developmental neuropsychological impairment 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/kg-day (Low end of BMDL05 range) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methylnaphthalene_419' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1006'>2-Methylnaphthalene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000091576'>91-57-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Pulmonary alveolar proteinosis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methylphenol_420' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=300'>2-Methylphenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095487'>95-48-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weights and neurotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Methylphenol_421' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=301'>3-Methylphenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108394'>108-39-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weights and neurotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Metolachlor_422' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=74'>Metolachlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000051218452'>51218-45-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain, decreased pup weight and parental food consumption 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Metribuzin_423' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=75'>Metribuzin</a> 
		</td>
	
		<td>
			<span id='sortby_000000021087649'>21087-64-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and kidney effects, decreased body weight, mortality 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Mirex_424' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=251'>Mirex</a> 
		</td>
	
		<td>
			<span id='sortby_000000002385855'>2385-85-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver cytomegaly, fatty metamorphosis, angiectasis; thyroid cystic follicles 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Molinate_425' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=298'>Molinate</a> 
		</td>
	
		<td>
			<span id='sortby_000000002212671'>2212-67-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reproductive toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Molybdenum_426' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=425'>Molybdenum</a> 
		</td>
	
		<td>
			<span id='sortby_000000007439987'>7439-98-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased uric acid levels 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Monochloramine_427' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=644'>Monochloramine</a> 
		</td>
	
		<td>
			<span id='sortby_000000010599903'>10599-90-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No observed effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Naled_428' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=175'>Naled</a> 
		</td>
	
		<td>
			<span id='sortby_000000000300765'>300-76-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Brain ChE inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Naphthalene_429' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=436'>Naphthalene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000091203'>91-20-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nasal effects: hyperplasia and metaplasia in respiratory and olfactory epithelium, respectively 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Naphthalene_430' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=436'>Naphthalene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000091203'>91-20-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased mean terminal body weight in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Napropamide_431' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=384'>Napropamide</a> 
		</td>
	
		<td>
			<span id='sortby_000000015299997'>15299-99-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain in parental animals and pups 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nickel_refinery_dust_432' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=272'>Nickel refinery dust</a> 
		</td>
	
		<td>
			<span id='sortby_000000000000000'></span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung cancer 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			2.4x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nickel_subsulfide_433' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=273'>Nickel subsulfide</a> 
		</td>
	
		<td>
			<span id='sortby_000000012035722'>12035-72-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Lung cancer 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.8x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nickel,_soluble_salts_434' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=271'>Nickel, soluble salts</a> 
		</td>
	
		<td>
			<span id='sortby_'>Various</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body and organ weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrate_435' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=76'>Nitrate</a> 
		</td>
	
		<td>
			<span id='sortby_000000014797558'>14797-55-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Early clinical signs of methemoglobinemia in excess of 10% (0-3 months old infants formula) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.6 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrite_436' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=78'>Nitrite</a> 
		</td>
	
		<td>
			<span id='sortby_000000014797650'>14797-65-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Methemoglobinemia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrobenzene_437' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=79'>Nitrobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098953'>98-95-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased methemoglobin levels 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrobenzene_438' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=79'>Nitrobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098953'>98-95-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Bronchiolization of the alveoli and olfactory degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrobenzene_439' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=79'>Nitrobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000098953'>98-95-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver hepatocellular adenomas or carcinomas, kidney tubular adenomas or carcinomas, thyroid follicular cell adenomas or carcinomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitroguanidine_440' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=402'>Nitroguanidine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000556887'>556-88-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced weight gain in female rats, maternal/ fetal toxicity in rats, and equivocal evidence of developmental toxicity in rabbits 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitropropane_441' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=519'>2-Nitropropane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079469'>79-46-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver focal vacuolization and nodules 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitroso-N-methylethylamine_442' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=179'>N-Nitroso-N-methylethylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000010595956'>10595-95-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.2x10<sup>1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitroso-di-n-butylamine_443' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=37'>N-Nitroso-di-n-butylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000924163'>924-16-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Bladder and esophagus tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5.4  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitroso-di-n-butylamine_444' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=37'>N-Nitroso-di-n-butylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000924163'>924-16-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Bladder and esophagus tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.6x10<sup>-3</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosodi-N-propylamine_445' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=177'>N-Nitrosodi-N-propylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000621647'>621-64-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7.0  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosodiethanolamine_446' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=252'>N-Nitrosodiethanolamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000001116547'>1116-54-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma, cholangiocellular carcinoma and adenoma and neoplastic nodules 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.8  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosodiethylamine_447' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=42'>N-Nitrosodiethylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000055185'>55-18-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.5x10<sup>2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosodiethylamine_448' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=42'>N-Nitrosodiethylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000055185'>55-18-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.3x10<sup>-2</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosodimethylamine_449' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=45'>N-Nitrosodimethylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062759'>62-75-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5.1x10<sup>1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosodimethylamine_450' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=45'>N-Nitrosodimethylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062759'>62-75-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver tumors 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.4x10<sup>-2</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosodiphenylamine_451' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=178'>N-Nitrosodiphenylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000086306'>86-30-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Transitional cell carcinoma of the bladder 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			4.9x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosopyrrolidine_452' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=81'>N-Nitrosopyrrolidine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000930552'>930-55-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma and adenoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.1  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Nitrosopyrrolidine_453' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=81'>N-Nitrosopyrrolidine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000930552'>930-55-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma and adenoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			6.1x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Norflurazon_454' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=82'>Norflurazon</a> 
		</td>
	
		<td>
			<span id='sortby_000000027314132'>27314-13-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and thyroid effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='NuStar_455' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=299'>NuStar</a> 
		</td>
	
		<td>
			<span id='sortby_000000085509199'>85509-19-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver cell enlargement 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Octabromodiphenyl_ether_456' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=180'>Octabromodiphenyl ether</a> 
		</td>
	
		<td>
			<span id='sortby_000000032536520'>32536-52-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Induction of hepatic enzymes; liver histopathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine_(HMX)_457' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=311'>Octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX)</a> 
		</td>
	
		<td>
			<span id='sortby_000000002691410'>2691-41-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatic lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Oryzalin_458' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=83'>Oryzalin</a> 
		</td>
	
		<td>
			<span id='sortby_000000019044883'>19044-88-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increases in serum cholesterol, alkaline phosphatase, and relative liver and kidney weights, and decreases in alanine transaminase and adrenal weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Oxadiazon_459' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=253'>Oxadiazon</a> 
		</td>
	
		<td>
			<span id='sortby_000000019666309'>19666-30-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased levels of serum proteins and increased liver weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Oxamyl_460' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=181'>Oxamyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000023135220'>23135-22-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain and food consumption 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Oxyfluorfen_461' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=84'>Oxyfluorfen</a> 
		</td>
	
		<td>
			<span id='sortby_000000042874033'>42874-03-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute liver weight and nonneoplastic lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Paclobutrazol_462' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=182'>Paclobutrazol</a> 
		</td>
	
		<td>
			<span id='sortby_000000076738620'>76738-62-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Elevated liver weights, serum cholesterol, hepatic aminopyrine N-demethylase activity, and alanine transaminase levels 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Paraquat_463' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=183'>Paraquat</a> 
		</td>
	
		<td>
			<span id='sortby_000000001910425'>1910-42-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Chronic pneumonitis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4.5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pendimethalin_464' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=292'>Pendimethalin</a> 
		</td>
	
		<td>
			<span id='sortby_000000040487421'>40487-42-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increase in serum alkaline phosphatase and liver weight, and hepatic lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pentabromodiphenyl_ether_465' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=184'>Pentabromodiphenyl ether</a> 
		</td>
	
		<td>
			<span id='sortby_000000032534819'>32534-81-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Induction of hepatic enzymes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pentabromodiphenyl_ether_(BDE-99)_466' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1008'>2,2',4,4',5-Pentabromodiphenyl ether (BDE-99)</a> 
		</td>
	
		<td>
			<span id='sortby_000000060348609'>60348-60-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurobehavioral effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pentachlorobenzene_467' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=85'>Pentachlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000608935'>608-93-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and kidney toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pentachloronitrobenzene_(PCNB)_468' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=254'>Pentachloronitrobenzene (PCNB)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000082688'>82-68-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pentachlorophenol_469' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=86'>Pentachlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000087865'>87-86-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pentachlorophenol_470' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=86'>Pentachlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000087865'>87-86-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenomas or carcinomas and adrenal benign or malignant pheochromocytomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			4x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perchlorate_(ClO4)_and_Perchlorate_Salts_471' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1007'>Perchlorate (ClO4) and Perchlorate Salts</a> 
		</td>
	
		<td>
			<span id='sortby_000000007790989'>7790-98-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Radioactive iodide uptake inhibition (RAIU) in the thyroid 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorobutanoic_Acid_(PFBA)_472' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=701'>Perfluorobutanoic Acid (PFBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000375224'>375-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased hepatocellular hypertrophy (Liver), Decreased total T4 (Thyroid)


		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorobutanoic_Acid_(PFBA)_473' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=701'>Perfluorobutanoic Acid (PFBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000375224'>375-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Developmental delays 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorobutanoic_Acid_(PFBA)_474' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=701'>Perfluorobutanoic Acid (PFBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000375224'>375-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased total T4 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorobutanoic_Acid_(PFBA)_475' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=701'>Perfluorobutanoic Acid (PFBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000375224'>375-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased hepatocellular hypertrophy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorobutanoic_Acid_(PFBA)_476' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=701'>Perfluorobutanoic Acid (PFBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000375224'>375-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Developmental delays 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorobutanoic_Acid_(PFBA)_477' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=701'>Perfluorobutanoic Acid (PFBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000375224'>375-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Developmental delays 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorobutanoic_Acid_(PFBA)_478' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=701'>Perfluorobutanoic Acid (PFBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000375224'>375-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased hepatocellular hypertrophy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorohexanoic_Acid_(PFHxA)_479' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=704'>Perfluorohexanoic Acid (PFHxA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000307244'>307-24-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased postnatal (PND 0) body weight in F1 Sprague‑Dawley male and female rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorohexanoic_Acid_(PFHxA)_480' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=704'>Perfluorohexanoic Acid (PFHxA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000307244'>307-24-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased hepatocellular hypertrophy in adult rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorohexanoic_Acid_(PFHxA)_481' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=704'>Perfluorohexanoic Acid (PFHxA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000307244'>307-24-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased red blood cells in adult female Crl:CD Sprague‑Dawley rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorohexanoic_Acid_(PFHxA)_482' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=704'>Perfluorohexanoic Acid (PFHxA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000307244'>307-24-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased hepatocellular hypertrophy in adult male Crl:CD Sprague‑Dawley rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-4</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorohexanoic_Acid_(PFHxA)_483' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=704'>Perfluorohexanoic Acid (PFHxA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000307244'>307-24-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased postnatal (PND 0) body weight in F1 Sprague‑Dawley male and female rats

		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorohexanoic_Acid_(PFHxA)_484' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=704'>Perfluorohexanoic Acid (PFHxA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000307244'>307-24-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased red blood cells in adult female Crl:CD Sprague‑Dawley rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-4</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Perfluorohexanoic_Acid_(PFHxA)_485' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=704'>Perfluorohexanoic Acid (PFHxA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000307244'>307-24-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased total T4 in adult male Harlan Sprague-Dawley rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Permethrin_486' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=185'>Permethrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000052645531'>52645-53-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phenmedipham_487' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=477'>Phenmedipham</a> 
		</td>
	
		<td>
			<span id='sortby_000000013684634'>13684-63-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phenol_488' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=88'>Phenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108952'>108-95-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased maternal weight gain 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phenylenediamine_489' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=87'>m-Phenylenediamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108452'>108-45-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased relative and absolute liver weights and degenerative liver lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phenylmercuric_acetate_490' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=89'>Phenylmercuric acetate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062384'>62-38-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal damage 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phosgene_491' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=487'>Phosgene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075445'>75-44-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Collagen staining indicative of fibrosis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phosmet_492' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=91'>Phosmet</a> 
		</td>
	
		<td>
			<span id='sortby_000000000732116'>732-11-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight (males), liver cell vacuolation, cholinesterase inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phosphine_493' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=90'>Phosphine</a> 
		</td>
	
		<td>
			<span id='sortby_000000007803512'>7803-51-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phosphine_494' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=90'>Phosphine</a> 
		</td>
	
		<td>
			<span id='sortby_000000007803512'>7803-51-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Body weight and clinical parameters 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phosphoric_acid_495' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=697'>Phosphoric acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000007664382'>7664-38-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Bronchiolar fibrosis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Phthalic_anhydride_496' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=308'>Phthalic anhydride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000085449'>85-44-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Lung and kidney histopathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2 mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Picloram_497' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=256'>Picloram</a> 
		</td>
	
		<td>
			<span id='sortby_000000001918021'>1918-02-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pirimiphos-methyl_498' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=257'>Pirimiphos-methyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000029232937'>29232-93-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Transient plasma ChE depression 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Polychlorinated_Biphenyls_(PCBs)_499' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=294'>Polychlorinated Biphenyls (PCBs)</a> 
		</td>
	
		<td>
			<span id='sortby_000000001336363'>1336-36-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver hepatocellular adenomas, carcinomas, cholangiomas, or cholangiocarcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Polychlorinated_Biphenyls_(PCBs)_500' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=294'>Polychlorinated Biphenyls (PCBs)</a> 
		</td>
	
		<td>
			<span id='sortby_000000001336363'>1336-36-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver hepatocellular adenomas, carcinomas, cholangiomas, or cholangiocarcinomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br>(Applies to inhalation of evaporated congeners) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Potassium_cyanide_501' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=92'>Potassium cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000151508'>151-50-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased cauda epididymis weight in male F344/N rats. The RfD for potassium cyanide is presented in section I.A.3 of the hydrogen cyanide and cyanide salts IRIS Summary. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Potassium_silver_cyanide_502' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=93'>Potassium silver cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000506616'>506-61-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased cauda epididymis weight in male F344/N rats. The RfD for potassium cyanide is presented in section I.A.3 of the hydrogen cyanide and cyanide salts IRIS Summary. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Prochloraz_503' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=378'>Prochloraz</a> 
		</td>
	
		<td>
			<span id='sortby_000000067747095'>67747-09-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increase in SAP and liver weights, liver histopathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Prochloraz_504' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=378'>Prochloraz</a> 
		</td>
	
		<td>
			<span id='sortby_000000067747095'>67747-09-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver adenoma/ carcinoma combined 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.5x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Prometon_505' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=94'>Prometon</a> 
		</td>
	
		<td>
			<span id='sortby_000000001610180'>1610-18-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No treatment related effects observed 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Prometryn_506' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=258'>Prometryn</a> 
		</td>
	
		<td>
			<span id='sortby_000000007287196'>7287-19-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and kidney degeneration and bone marrow atrophy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pronamide_507' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=95'>Pronamide</a> 
		</td>
	
		<td>
			<span id='sortby_000000023950585'>23950-58-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propachlor_508' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=96'>Propachlor</a> 
		</td>
	
		<td>
			<span id='sortby_000000001918167'>1918-16-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased weight gain, food consumption increased relative liver weights 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propanil_509' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=186'>Propanil</a> 
		</td>
	
		<td>
			<span id='sortby_000000000709988'>709-98-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased relative spleen weight in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propargite_510' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=296'>Propargite</a> 
		</td>
	
		<td>
			<span id='sortby_000000002312358'>2312-35-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight gain (maternal), increased resorption, reduced body weight (fetal), delayed ossification 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day (Maternal toxicity and fetotoxicity) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propargyl_alcohol_511' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=468'>Propargyl alcohol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107197'>107-19-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Renal and hepatotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propazine_512' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=187'>Propazine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000139402'>139-40-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decrease in body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propham_513' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=260'>Propham</a> 
		</td>
	
		<td>
			<span id='sortby_000000000122429'>122-42-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increase in male spleen weight and ChE depression in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propiconazole_514' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=282'>Propiconazole</a> 
		</td>
	
		<td>
			<span id='sortby_000000060207901'>60207-90-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Gastric mucosal irritation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propionaldehyde_515' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1011'>Propionaldehyde</a> 
		</td>
	
		<td>
			<span id='sortby_000000000123386'>123-38-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Atrophy of olfactory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			8x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propylene_glycol_monomethyl_ether_(PGME)_516' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=404'>Propylene glycol monomethyl ether (PGME)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000107982'>107-98-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mild reversible sedation 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propylene_oxide_517' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=403'>Propylene oxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075569'>75-56-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nest-like infolds of the nasal respiratory epithelium 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propylene_oxide_518' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=403'>Propylene oxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075569'>75-56-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Nasal cavity hemangioma or hemangiosarcoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3.7x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Propylene_oxide_519' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=403'>Propylene oxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075569'>75-56-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Forestomach, squamous cell carcinoma 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.4x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pursuit_520' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=439'>Pursuit</a> 
		</td>
	
		<td>
			<span id='sortby_000000081335775'>81335-77-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased packed cell volume, hemoglobin, erythrocytes in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pydrin_521' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=188'>Pydrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000051630581'>51630-58-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurological dysfunction 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pyrene_522' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=445'>Pyrene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000129000'>129-00-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney effects (renal tubular pathology, decreased kidney weights) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Pyridine_523' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=261'>Pyridine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000110861'>110-86-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Quinalphos_524' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=189'>Quinalphos</a> 
		</td>
	
		<td>
			<span id='sortby_000000013593038'>13593-03-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			No adverse effects reported 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Quinoline_525' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1004'>Quinoline</a> 
		</td>
	
		<td>
			<span id='sortby_000000000091225'>91-22-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatic hemangioendotheliomas or hemangiosarcomas 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Resmethrin_526' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=343'>Resmethrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000010453868'>10453-86-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reproductive toxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Rotenone_527' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=344'>Rotenone</a> 
		</td>
	
		<td>
			<span id='sortby_000000000083794'>83-79-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced pup weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Savey_528' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=345'>Savey</a> 
		</td>
	
		<td>
			<span id='sortby_000000078587050'>78587-05-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hypertrophy of adrenal cortex (both sexes) hematologic effects (males) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Selenious_acid_529' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=97'>Selenious acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000007783008'>7783-00-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Clinical selenosis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Selenium_and_Compounds_530' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=472'>Selenium and Compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000007782492'>7782-49-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Clinical selenosis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Sethoxydim_531' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=190'>Sethoxydim</a> 
		</td>
	
		<td>
			<span id='sortby_000000074051802'>74051-80-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mild anemia in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Silver_532' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=99'>Silver</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440224'>7440-22-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Argyria 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Silver_cyanide_533' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=100'>Silver cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000506649'>506-64-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Weight loss, thyroid effects, and myelin degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Simazine_534' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=263'>Simazine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000122349'>122-34-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduction in weight gains hematological changes in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Sodium_azide_535' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=191'>Sodium azide</a> 
		</td>
	
		<td>
			<span id='sortby_000000026628228'>26628-22-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Clinical sign (e.g., hunched postures) and reduced body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Sodium_cyanide_536' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=101'>Sodium cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000143339'>143-33-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased cauda epididymis weight in male F344/N rats. The RfD for potassium cyanide is presented in section I.A.3 of the hydrogen cyanide and cyanide salts IRIS Summary. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Sodium_diethyldithiocarbamate_537' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=102'>Sodium diethyldithiocarbamate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000148185'>148-18-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Sodium_fluoroacetate_538' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=469'>Sodium fluoroacetate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000062748'>62-74-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased heart weight in females and males; decreased testis weight and altered spermatogenesis in males. 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Strontium_539' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=550'>Strontium</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440246'>7440-24-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Rachitic bone 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Strychnine_540' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=103'>Strychnine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000057249'>57-24-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Toxicity/histopathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Styrene_541' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=104'>Styrene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000100425'>100-42-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Red blood cell and liver effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Styrene_542' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=104'>Styrene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000100425'>100-42-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			CNS effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Systhane_543' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=342'>Systhane</a> 
		</td>
	
		<td>
			<span id='sortby_000000088671890'>88671-89-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Testicular atrophy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tebuthiuron_544' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=264'>Tebuthiuron</a> 
		</td>
	
		<td>
			<span id='sortby_000000034014181'>34014-18-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Depressed body weight gain in F1 females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Terbacil_545' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=105'>Terbacil</a> 
		</td>
	
		<td>
			<span id='sortby_000000005902512'>5902-51-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increase in thyroid/body weight ratio; slight increase in liver weights; elevated alkaline phosphatase 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Terbutryn_546' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=285'>Terbutryn</a> 
		</td>
	
		<td>
			<span id='sortby_000000000886500'>886-50-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hematologic effects in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrabromodiphenyl_ether_(BDE-47)_547' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1010'>2,2',4,4'-Tetrabromodiphenyl ether (BDE-47)</a> 
		</td>
	
		<td>
			<span id='sortby_000000005436431'>5436-43-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurobehavioral effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachlorobenzene_548' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=107'>1,2,4,5-Tetrachlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095943'>95-94-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Kidney lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachlorodibenzo-p-dioxin_549' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1024'>2,3,7,8-Tetrachlorodibenzo-p-dioxin</a> 
		</td>
	
		<td>
			<span id='sortby_000000001746016'>1746-01-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased sperm count and motility in men exposed to TCDD as boys / Increased TSH in neonates 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-10</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachlorodibenzo-p-dioxin_550' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1024'>2,3,7,8-Tetrachlorodibenzo-p-dioxin</a> 
		</td>
	
		<td>
			<span id='sortby_000000001746016'>1746-01-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased sperm count and motility in men exposed to TCDD as boys / Increased TSH in neonates 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7x10<sup>-10</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethane_551' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=265'>1,1,1,2-Tetrachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000630206'>630-20-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenoma or carcinoma 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			7.4x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethane_552' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=265'>1,1,1,2-Tetrachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000630206'>630-20-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mineralization of the kidneys in males, hepatic clear cell change in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethane_553' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=265'>1,1,1,2-Tetrachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000630206'>630-20-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenoma or carcinoma 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.6x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethane_554' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=193'>1,1,2,2-Tetrachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079345'>79-34-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			hepatocellular carcinomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2x10<sup>-1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethane_555' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=193'>1,1,2,2-Tetrachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079345'>79-34-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased relative liver weight in rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethane_556' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=193'>1,1,2,2-Tetrachloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079345'>79-34-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased relative liver weight in rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethylene_(Perchloroethylene)_557' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=106'>Tetrachloroethylene (Perchloroethylene)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000127184'>127-18-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			(See Note) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			6x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethylene_(Perchloroethylene)_558' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=106'>Tetrachloroethylene (Perchloroethylene)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000127184'>127-18-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			(See Note) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethylene_(Perchloroethylene)_559' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=106'>Tetrachloroethylene (Perchloroethylene)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000127184'>127-18-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenomas or carcinomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			0   </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachloroethylene_(Perchloroethylene)_560' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=106'>Tetrachloroethylene (Perchloroethylene)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000127184'>127-18-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenomas or carcinomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			2.1x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachlorophenol_561' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=108'>2,3,4,6-Tetrachlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000058902'>58-90-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver weights and centrilobular hypertrophy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrachlorovinphos_562' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=194'>Tetrachlorovinphos</a> 
		</td>
	
		<td>
			<span id='sortby_000000000961115'>961-11-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight gain, increased liver and kidney weights, and RBC ChE inhibition 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetraethyl_lead_563' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=109'>Tetraethyl lead</a> 
		</td>
	
		<td>
			<span id='sortby_000000000078002'>78-00-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Histopathology of liver and thymus 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-7</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetraethyldithiopyrophosphate_564' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=330'>Tetraethyldithiopyrophosphate</a> 
		</td>
	
		<td>
			<span id='sortby_000000003689245'>3689-24-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Depressed RBC and plasma cholinesterase activity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrafluoroethane_565' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=656'>1,1,1,2-Tetrafluoroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000811972'>811-97-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Leydig cell hyperplasia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			8x10<sup>1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrahydrofuran_566' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1023'>Tetrahydrofuran</a> 
		</td>
	
		<td>
			<span id='sortby_000000000109999'>109-99-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pup body weight gain 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tetrahydrofuran_567' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1023'>Tetrahydrofuran</a> 
		</td>
	
		<td>
			<span id='sortby_000000000109999'>109-99-9</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver weight and centrilobular cytomegaly, CNS effects (narcosis) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Thiobencarb_568' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=266'>Thiobencarb</a> 
		</td>
	
		<td>
			<span id='sortby_000000028249776'>28249-77-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decrease in body weight, increase in BUN 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Thiophanate-methyl_569' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=117'>Thiophanate-methyl</a> 
		</td>
	
		<td>
			<span id='sortby_000000023564058'>23564-05-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight, decreased spermatogenesis, and histological evidence of hyperthyroidism 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Thiram_570' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=267'>Thiram</a> 
		</td>
	
		<td>
			<span id='sortby_000000000137268'>137-26-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Toluene_571' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=118'>Toluene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108883'>108-88-3</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Neurological effects in occupationally-exposed workers 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Toluene_572' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=118'>Toluene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108883'>108-88-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased kidney weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Toluene_diisocyanate_mixture_(TDI)_573' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=503'>2,4-/2,6-Toluene diisocyanate mixture (TDI)</a> 
		</td>
	
		<td>
			<span id='sortby_000000026471625'>26471-62-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Chronic lung-function decline 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7x10<sup>-5</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Toxaphene_574' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=346'>Toxaphene</a> 
		</td>
	
		<td>
			<span id='sortby_000000008001352'>8001-35-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas and neoplastic nodules 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3.2x10<sup>-4</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Toxaphene_575' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=346'>Toxaphene</a> 
		</td>
	
		<td>
			<span id='sortby_000000008001352'>8001-35-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinomas and neoplastic nodules 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.1  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tralomethrin_576' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=385'>Tralomethrin</a> 
		</td>
	
		<td>
			<span id='sortby_000000066841256'>66841-25-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight gain in males increased food and water consumption in males and females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7.5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Triallate_577' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=195'>Triallate</a> 
		</td>
	
		<td>
			<span id='sortby_000000002303175'>2303-17-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased hemosiderin deposition, serum alkaline phosphatase, and liver weight in females 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1.3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Triasulfuron_578' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=510'>Triasulfuron</a> 
		</td>
	
		<td>
			<span id='sortby_000000082097505'>82097-50-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Centrilobular hepatocytomegaly in males 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tribromobenzene_579' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=196'>1,2,4-Tribromobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000615543'>615-54-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver-to-body weight ratio and hepatic microsomal enzyme induction 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tributyltin_oxide_(TBTO)_580' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=349'>Tributyltin oxide (TBTO)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000056359'>56-35-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Immunosuppression 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloro-1,2,2-trifluoroethane_(CFC-113)_581' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=123'>1,1,2-Trichloro-1,2,2-trifluoroethane (CFC-113)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000076131'>76-13-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Psychomotor impairment 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroacetic_acid_582' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=655'>Trichloroacetic acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000076039'>76-03-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hepatocellular necrosis 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroacetic_acid_583' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=655'>Trichloroacetic acid</a> 
		</td>
	
		<td>
			<span id='sortby_000000000076039'>76-03-9</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular adenomas or carcinomas 
		</td>
	
		<td>
			Suggestive evidence of carcinogenic potential (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichlorobenzene_584' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=119'>1,2,4-Trichlorobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000120821'>120-82-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased adrenal weights; vacuolization of zona fasciculata in the cortex 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_585' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Performance on neurobehavioral tests 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			9 mg/m<sup>3</sup> (Acute: 1 hour) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_586' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2 mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_587' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduced body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7 mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_588' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Performance on neurobehavioral tests 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7 mg/m<sup>3</sup> (Acute: 4 hours) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_589' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver histopathologic changes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5 mg/m<sup>3</sup> (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_590' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver histopathologic changes 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5 mg/m<sup>3</sup> (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_591' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Performance on neurobehavioral tests 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7 mg/m<sup>3</sup> (Acute: 8 hours) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_592' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Performance on neurobehavioral tests 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6 mg/m<sup>3</sup> (Acute: 24 hours) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_593' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=197'>1,1,1-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071556'>71-55-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Performance on neurobehavioral tests 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5 mg/m<sup>3</sup> (Short-term) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_594' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=198'>1,1,2-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079005'>79-00-5</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			1.6x10<sup>-5</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_595' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=198'>1,1,2-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079005'>79-00-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Clinical serum chemistry (effects on erythrocytes and depressed humoral immune status) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethane_596' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=198'>1,1,2-Trichloroethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079005'>79-00-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Hepatocellular carcinoma 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5.7x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethylene_597' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=199'>Trichloroethylene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079016'>79-01-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Renal cell carcinoma, non-Hodgkin's lymphoma, and liver tumors 
		</td>
	
		<td>
			Carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			4.6 x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethylene_598' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=199'>Trichloroethylene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079016'>79-01-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Renal cell carcinoma, non-Hodgkin's lymphoma, and liver tumors 
		</td>
	
		<td>
			Carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.1x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethylene_599' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=199'>Trichloroethylene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079016'>79-01-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			(See Note) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloroethylene_600' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=199'>Trichloroethylene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000079016'>79-01-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			(See Note) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichlorofluoromethane_601' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=120'>Trichlorofluoromethane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075694'>75-69-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Survival and histopathology (pleuritis and pericarditis) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichlorophenol_602' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=121'>2,4,5-Trichlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095954'>95-95-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver and kidney pathology 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichlorophenol_603' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=122'>2,4,6-Trichlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000088062'>88-06-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Leukemia 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.1x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichlorophenol_604' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=122'>2,4,6-Trichlorophenol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000088062'>88-06-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Leukemia 
		</td>
	
		<td>
			B2 (Probable human carcinogen - based on sufficient evidence of carcinogenicity in animals) (1986 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			3.1x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichlorophenoxy)_propionic_acid_(2,4,5-TP)_605' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=323'>2(2,4,5-Trichlorophenoxy) propionic acid (2,4,5-TP)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000093721'>93-72-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Histopathological changes in liver 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			8x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichlorophenoxyacetic_acid_(2,4,5-T)_606' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=262'>2,4,5-Trichlorophenoxyacetic acid (2,4,5-T)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000093765'>93-76-5</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased urinary coproporphyrins 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloropropane_607' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=372'>1,1,2-Trichloropropane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000598776'>598-77-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Mild lesions in liver, kidney and thyroid 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloropropane_608' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=200'>1,2,3-Trichloropropane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000096184'>96-18-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased absolute liver weight in male rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloropropane_609' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=200'>1,2,3-Trichloropropane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000096184'>96-18-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			alimentary system squamous cell neoplasms, liver hepatocellular adenomas or carcinomas, Harderian gland adenomas, uterine/cervix adenomas or carcinomas 
		</td>
	
		<td>
			Likely to be carcinogenic to humans (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3x10<sup>1</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trichloropropane_610' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=200'>1,2,3-Trichloropropane</a> 
		</td>
	
		<td>
			<span id='sortby_000000000096184'>96-18-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			peribronchial lymphoid hyperplasia in male rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Tridiphane_611' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=124'>Tridiphane</a> 
		</td>
	
		<td>
			<span id='sortby_000000058138082'>58138-08-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased fertility index and depressed body weight of dams 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Triethylamine_612' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=520'>Triethylamine</a> 
		</td>
	
		<td>
			<span id='sortby_000000000121448'>121-44-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Inflammation of the nasal passage 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			7x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trifluralin_613' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=268'>Trifluralin</a> 
		</td>
	
		<td>
			<span id='sortby_000000001582098'>1582-09-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Combined renal pelvis carcinomas, urinary bladder papillomas and/or thyroid adenomas and carcinomas 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7.7x10<sup>-3</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trifluralin_614' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=268'>Trifluralin</a> 
		</td>
	
		<td>
			<span id='sortby_000000001582098'>1582-09-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased liver weights; increase in methemoglobin 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			7.5x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_615' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1039'>1,2,3-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000526738'>526-73-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/m<sup>3</sup> (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_616' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1039'>1,2,3-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000526738'>526-73-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_617' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1039'>1,2,3-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000526738'>526-73-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_618' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1039'>1,2,3-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000526738'>526-73-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Inflammatory lung lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_619' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1039'>1,2,3-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000526738'>526-73-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_620' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1039'>1,2,3-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000526738'>526-73-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased segmented neutrophils 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_621' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Inflammatory lung lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_622' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased fetal weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_623' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased maternal weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_624' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_625' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_626' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/m<sup>3</sup> (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_627' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_628' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1037'>1,2,4-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000095636'>95-63-6</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased clotting time 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			8x10<sup>-2</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_629' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1038'>1,3,5-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108678'>108-67-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_630' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1038'>1,3,5-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108678'>108-67-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-2</sup> mg/kg-day (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_631' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1038'>1,3,5-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108678'>108-67-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased fetal weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_632' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1038'>1,3,5-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108678'>108-67-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			6x10<sup>-2</sup> mg/m<sup>3</sup> (Chronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_633' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1038'>1,3,5-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108678'>108-67-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased pain sensitivity in male Wistar rats 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-2</sup> mg/kg-day (Subchronic) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trimethylbenzene_634' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1038'>1,3,5-Trimethylbenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108678'>108-67-8</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased maternal weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			4x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trinitrobenzene_635' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=316'>1,3,5-Trinitrobenzene</a> 
		</td>
	
		<td>
			<span id='sortby_000000000099354'>99-35-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Methemoglobinemia and spleen-erythroid cell hyperplasia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trinitrotoluene_(TNT)_636' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=269'>2,4,6-Trinitrotoluene (TNT)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000118967'>118-96-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver effects 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Trinitrotoluene_(TNT)_637' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=269'>2,4,6-Trinitrotoluene (TNT)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000118967'>118-96-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Urinary bladder, transitional cell papilloma and transitional squamous cell carcinomas 
		</td>
	
		<td>
			C (Possible human carcinogen) (1986 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			3.0x10<sup>-2</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Uranium,_soluble_salts_638' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=421'>Uranium, soluble salts</a> 
		</td>
	
		<td>
			<span id='sortby_'>Various</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Initial body weight loss moderate nephrotoxicity 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vanadium_pentoxide_639' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=125'>Vanadium pentoxide</a> 
		</td>
	
		<td>
			<span id='sortby_000000001314621'>1314-62-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased hair cystine 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			9x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vernam_640' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=201'>Vernam</a> 
		</td>
	
		<td>
			<span id='sortby_000000001929777'>1929-77-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinclozolin_641' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=126'>Vinclozolin</a> 
		</td>
	
		<td>
			<span id='sortby_000000050471448'>50471-44-8</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Organ weight changes (adrenal and kidney) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2.5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_acetate_642' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=512'>Vinyl acetate</a> 
		</td>
	
		<td>
			<span id='sortby_000000000108054'>108-05-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Nasal epithelial lesions 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_bromide_643' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=671'>Vinyl bromide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000593602'>593-60-2</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hypertrophy, basophilic and eosinophilic foci, in the liver 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_644' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			8.8x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br>(Continuous lifetime exposure from birth) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_645' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7.2x10<sup>-1</sup>  per mg/kg-day </br>(Continuous lifetime exposure during adulthood) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_646' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			7.5x10<sup>-1</sup>  per mg/kg-day </br>(Continuous lifetime exposure during adulthood) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_647' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.4  per mg/kg-day </br>(Continuous lifetime exposure from birth) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_648' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.4x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br>(Continuous lifetime exposure during adulthood) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_649' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			8.8x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br>(Continuous lifetime exposure from birth) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_650' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Total of liver angiosarcoma, hepatocellular carcinoma, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			1.5  per mg/kg-day </br>(Continuous lifetime exposure from birth) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_651' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver cell polymorphism 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-3</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_652' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Liver cell polymorphism 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Vinyl_chloride_653' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1001'>Vinyl chloride</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075014'>75-01-4</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Liver angiosarcomas, angiomas, hepatomas, and neoplastic nodules 
		</td>
	
		<td>
			A (Human carcinogen) (1986 guidelines)  Known/likely human carcinogen (1996 guidelines)  
		</td>
	
		<td>
			Inhalation Unit Risk 
		</td>
	
		<td>
			4.4x10<sup>-6</sup>  per &micro;g/m<sup>3</sup> </br>(Continuous lifetime exposure during adulthood) 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Warfarin_654' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=202'>Warfarin</a> 
		</td>
	
		<td>
			<span id='sortby_000000000081812'>81-81-2</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased prothrombin time 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='White_phosphorus_655' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=460'>White phosphorus</a> 
		</td>
	
		<td>
			<span id='sortby_000000007723140'>7723-14-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Parturition mortality; forelimb hair loss 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-5</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Xylenes_656' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=270'>Xylenes</a> 
		</td>
	
		<td>
			<span id='sortby_000000001330207'>1330-20-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreased body weight, increased mortality 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			2x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Xylenes_657' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=270'>Xylenes</a> 
		</td>
	
		<td>
			<span id='sortby_000000001330207'>1330-20-7</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Impaired motor coordination (decreased rotarod performance) 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Zinc_and_Compounds_658' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=426'>Zinc and Compounds</a> 
		</td>
	
		<td>
			<span id='sortby_000000007440666'>7440-66-6</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Decreases in erythrocyte Cu, Zn-superoxide dismutase (ESOD) activity in healthy adult male and female volunteers 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Zinc_cyanide_659' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=127'>Zinc cyanide</a> 
		</td>
	
		<td>
			<span id='sortby_000000000557211'>557-21-1</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Weight loss, thyroid effects, and myelin degeneration 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Zinc_phosphide_660' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=203'>Zinc phosphide</a> 
		</td>
	
		<td>
			<span id='sortby_000000001314847'>1314-84-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Reduction of food intake and body weight 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			3x10<sup>-4</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='Zineb_661' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=204'>Zineb</a> 
		</td>
	
		<td>
			<span id='sortby_000000012122677'>12122-67-7</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Thyroid hyperplasia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			5x10<sup>-2</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='n-Butanol_662' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=140'>n-Butanol</a> 
		</td>
	
		<td>
			<span id='sortby_000000000071363'>71-36-3</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Hypoactivity and ataxia 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			1x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='tert-Butyl_Alcohol_(tBA)_663' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1036'>tert-Butyl Alcohol (tBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075650'>75-65-0</span> 
		</td>
	
		<td>
			Inhalation 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased severity of nephropathy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfC 
		</td>
	
		<td>
			5 mg/m<sup>3</sup> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='tert-Butyl_Alcohol_(tBA)_664' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1036'>tert-Butyl Alcohol (tBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075650'>75-65-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Cancer 
		</td>
	
		<td>
			Renal adenomas and carcinomas, thyroid adenomas 
		</td>
	
		<td>
			Suggestive evidence of carcinogenic potential (2005 guidelines)  
		</td>
	
		<td>
			Oral Slope Factor 
		</td>
	
		<td>
			5x10<sup>-4</sup>  per mg/kg-day </br> 
		</td>
	
  </tr>
  
  <tr>
	
		<td>
			<a id='tert-Butyl_Alcohol_(tBA)_665' href='https://cfpub.epa.gov/ncea/iris2/chemicalLanding.cfm?substance_nmbr=1036'>tert-Butyl Alcohol (tBA)</a> 
		</td>
	
		<td>
			<span id='sortby_000000000075650'>75-65-0</span> 
		</td>
	
		<td>
			Oral 
		</td>
	
		<td>
			 Noncancer 
		</td>
	
		<td>
			Increased severity of nephropathy 
		</td>
	
		<td>
			 n/a 
		</td>
	
		<td>
			RfD 
		</td>
	
		<td>
			4x10<sup>-1</sup> mg/kg-day 
		</td>
	
  </tr>
  
  </tbody>
</table>


</body>